{"gene":"TIAM1","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1995,"finding":"Tiam1 functions as a GDP-dissociation stimulator (GDS/GEF) for Rho-like GTPases in vitro, with preferential activity toward Rac1. In fibroblasts, Tiam1 induces membrane ruffling identical to constitutively active V12Rac1, and this phenotype is inhibited by dominant-negative N17Rac1, establishing Tiam1 as a Rac-specific GEF that drives actin cytoskeletal remodeling.","method":"In vitro GDS assay; dominant-negative Rac1 inhibition; morphological analysis in fibroblasts","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic assay combined with dominant-negative epistasis, replicated across multiple subsequent studies","pmids":["7753201"],"is_preprint":false},{"year":1995,"finding":"N-terminal truncation of Tiam1 activates its oncogenic potential in NIH3T3 cells, establishing Tiam1 as a proto-oncogene whose N-terminal sequences suppress transformation but are required for membrane ruffling. Constitutively active V12Rac1 phenocopies Tiam1-induced oncogenic transformation, placing Rac1 downstream of Tiam1.","method":"Overexpression of truncation mutants in NIH3T3 focus formation assay; comparison with V12Rac1","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis with defined phenotypic readouts, consistent with parallel Nature paper","pmids":["8570171"],"is_preprint":false},{"year":1997,"finding":"Tiam1 localizes to adherens junctions in epithelial MDCK cells, where it promotes E-cadherin-mediated cell-cell adhesion and suppresses HGF-induced cell scattering and invasion. Expression of Tiam1 or RacV12 in Ras-transformed MDCK cells restores E-cadherin adhesion and causes phenotypic reversion.","method":"Ectopic expression, immunolocalization, HGF-induced scattering assay, invasion assay in MDCK cells","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gain-of-function with defined cellular phenotype, replicated in multiple epithelial contexts","pmids":["9367959"],"is_preprint":false},{"year":1997,"finding":"Lysophosphatidic acid (LPA) and other agonists induce threonine phosphorylation of Tiam1 in Swiss 3T3 fibroblasts via protein kinase C. PKC inhibition reduces LPA-stimulated Tiam1 phosphorylation by ~75%, and PKC phosphorylates purified Tiam1 on threonine in vitro.","method":"In vivo phosphorylation assay; PKC inhibitor Ro-31-8220; PMA treatment; in vitro kinase assay with purified Tiam1","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus in vivo pharmacological validation, single lab","pmids":["9407095"],"is_preprint":false},{"year":1998,"finding":"The Tiam1/Rac signaling response in epithelial cells is substrate-dependent: on fibronectin/laminin-1 Tiam1 promotes E-cadherin-mediated adhesion and inhibits migration, while on collagen it promotes migration. PI3-kinase acts upstream of Tiam1 and Rac, as PI3K inhibition blocks Tiam1-induced but not V12Rac-induced effects. Tiam1 localizes to adherens junctions in non-motile cells and to lamellipodia in migrating cells.","method":"Substrate-dependent migration/adhesion assays; PI3K inhibition; GST-PAK pulldown for Rac-GTP; immunolocalization","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, PI3K epistasis defined, replicated across substrates","pmids":["9832565"],"is_preprint":false},{"year":1999,"finding":"Both protein kinase Cα and Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylate Tiam1 in vivo. CaMKII phosphorylates Tiam1 in vitro and enhances its nucleotide exchange activity toward Rac1 approximately 2-fold. Protein phosphatase 1 dephosphorylates Tiam1 in vitro and abolishes CaMKII-mediated activation.","method":"Intracellular Ca2+ manipulation; in vitro kinase assay (CaMKII); in vitro phosphatase assay (PP1); nucleotide exchange activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro kinase/phosphatase assay with functional (GEF activity) readout, single lab","pmids":["10212259"],"is_preprint":false},{"year":2000,"finding":"CD44v3 isoform physically associates with Tiam1 in breast tumor cells in vivo. The PHn-CC-Ex domain (aa 393–738) of Tiam1 is the primary CD44-binding region (Kd ~0.2 nM by Scatchard analysis). HA binding to CD44v3 stimulates Tiam1-catalyzed Rac1 activation and cell migration; disrupting CD44-Tiam1 interaction with the PHn-CC-Ex fragment blocks both.","method":"Co-immunoprecipitation; in vitro binding assay with recombinant fragment; Scatchard plot; Rac1 activation assay; migration assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, in vitro binding with Kd determination, functional rescue/block, single lab","pmids":["10636882"],"is_preprint":false},{"year":2000,"finding":"Ankyrin binds directly to Tiam1 via the ankyrin repeat domain (ARD), and the 11-aa sequence aa717-727 of Tiam1 is the ankyrin-binding domain. Ankyrin binding to Tiam1 activates GDP/GTP exchange on Rac1. Blocking this interaction with a Tiam1 fragment (aa393-728) inhibits Rac1 activation and breast tumor cell invasion.","method":"Co-immunoprecipitation; deletion mutation analysis; in vitro binding assay; GEF activity assay; tumor invasion assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding with defined domain, GEF activity assay, competitive inhibitor used, single lab","pmids":["10893266"],"is_preprint":false},{"year":2000,"finding":"The N-terminal pleckstrin homology (N-PH) domain of Tiam1 binds phosphoinositides with rank order PtdIns(3,4,5)P3 > PtdIns(3,4)P2 >> PtdIns(4,5)P2. PtdIns(3,4,5)P3 and PtdIns(3,4)P2 enhance Tiam1 GEF activity in vitro. The N-PH domain is required for PI3K-dependent Rac1 activation and membrane ruffling in cells.","method":"Lipid-binding assay; in vitro GEF activity assay; co-expression with constitutively active PI3K; domain deletion mutants","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro lipid-binding and GEF activity assays with domain mutagenesis, single lab","pmids":["10998360"],"is_preprint":false},{"year":2001,"finding":"Tiam1 localizes to microtubules in the nascent axon growth cone of cultured neurons. Overexpression of Tiam1 induces formation of multiple axon-like neurites, whereas suppression of Tiam1 prevents axon formation and growth cone cytoskeletal reorganization, indicating Tiam1 regulates axon specification through Rac1-dependent actin organization.","method":"Tiam1 overexpression and suppression; immunolocalization; cytochalasin D treatment; neuronal morphology analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function with defined morphological readout, single lab","pmids":["11264310"],"is_preprint":false},{"year":2002,"finding":"Tiam1 preferentially associates with activated GTP-bound Ras through a Ras-binding domain (RBD). Activated Ras and Tiam1 cooperate to produce synergistic Rac-GTP formation in a PI3K-independent manner, establishing Tiam1 as a direct Ras effector that mediates Ras activation of Rac.","method":"GST pulldown of GTP-Ras with Tiam1 RBD; Rac-GTP measurement (PAK-PBD pulldown) with PI3K inhibitors; co-expression of activated Ras and Tiam1","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct binding assay plus PI3K-independent epistasis with multiple controls, single lab","pmids":["12134164"],"is_preprint":false},{"year":2002,"finding":"Tiam1-deficient mice are resistant to Ras-induced skin tumorigenesis. Loss of Tiam1 is associated with increased apoptosis during tumor initiation and impeded proliferation during promotion. Tiam1-deficient primary embryonic fibroblasts resist RasV12-induced focus formation. Tumor number was Tiam1 gene-dose dependent.","method":"Tiam1 knockout mice; DMBA/TPA skin tumor model; focus formation assay with primary MEFs","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout model with defined phenotype, gene dosage effect, and in vitro MEF validation","pmids":["12075356"],"is_preprint":false},{"year":2002,"finding":"The N-terminal region of Tiam1 (containing PH domain, coiled-coil, and additional sequences) binds the scaffold protein IB2/JIP2. IB2/JIP2 simultaneously binds MLK3, MKK3, and p38 MAPK. Tiam1 binding to IB2/JIP2 potentiates p38 MAP kinase cascade activation but not JNK activation, revealing that scaffold association directs Rac signaling specificity.","method":"Yeast two-hybrid; co-immunoprecipitation; p38/JNK kinase assays; domain-deletion mapping","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, kinase assays, but single lab","pmids":["12024021"],"is_preprint":false},{"year":2004,"finding":"Tiam1 interacts with ephrin-B1 and EphA2 and mediates Rac1 activation and neurite outgrowth in response to both ephrin-B1 reverse signaling (via clustered EphB2) and EphA2 forward signaling (via ephrin-A1). Dominant-negative Tiam1 blocks neurite outgrowth induced by these Eph/ephrin signals.","method":"Co-immunoprecipitation; Rac1 activation assay; dominant-negative Tiam1 inhibition; neurite outgrowth assay in cortical neurons and neuroblastoma cells","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus dominant-negative epistasis with functional readout, single lab","pmids":["14988728"],"is_preprint":false},{"year":2004,"finding":"Tiam1 is required for the formation and maintenance of cadherin-based adherens junctions in MDCK cells. siRNA-mediated knockdown of Tiam1 causes junction disassembly and acquisition of a mesenchymal migratory phenotype. E1A-induced epithelial reversion requires Tiam1 upregulation and Rac activation.","method":"siRNA knockdown; E1A expression; Rac activation assay; Tiam1 KO primary MEFs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA loss-of-function with specific adhesion phenotype, confirmed in Tiam1 KO MEFs","pmids":["15138270"],"is_preprint":false},{"year":2005,"finding":"Par-3 directly binds the C-terminal region of Tiam1. Knockdown of Par-3 leads to constitutive Rac activation and disrupted tight junction assembly; this is rescued by dominant-negative Rac or by Tiam1 knockdown. Thus Par-3 spatially restrains Tiam1-mediated Rac activity to control tight junction assembly.","method":"Co-immunoprecipitation; Par-3 siRNA knockdown; dominant-negative Rac rescue; Tiam1 siRNA; tight junction formation assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding assay, multiple genetic epistasis experiments, replicated independently in parallel study","pmids":["15723052"],"is_preprint":false},{"year":2005,"finding":"PAR-3 directly interacts with STEF/Tiam1 and recruits them into the PAR-3-aPKC-PAR-6-Cdc42-GTP complex. This complex mediates Cdc42-induced Rac activation and lamellipodia formation. Disrupting PAR-3-STEF/Tiam1 interaction inhibits Cdc42-induced lamellipodia but not filopodia. STEF/Tiam1 accumulates at the axon tip and is required for neuronal polarity.","method":"Co-immunoprecipitation; complex reconstitution; dominant-negative disruption; lamellipodia/filopodia morphology assay; hippocampal neuron imaging","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — complex formation, genetic epistasis, independent replication in parallel study","pmids":["15723051"],"is_preprint":false},{"year":2005,"finding":"Tiam1 is present in dendrites and spines and interacts with the NMDA receptor. NMDA receptor stimulation induces calcium-dependent phosphorylation of Tiam1. RNAi knockdown and dominant-interfering Tiam1 mutants impair dendritic arbor and spine development via Rac1-dependent actin remodeling.","method":"Co-immunoprecipitation with NMDAR; in vivo phosphorylation assay; RNAi knockdown; dominant-negative Tiam1; dendritic morphology analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct interaction, phosphorylation, multiple loss-of-function approaches, defined morphological phenotype","pmids":["15721239"],"is_preprint":false},{"year":2005,"finding":"Tiam1 is required for alpha3beta1 integrin-mediated Rac activation, laminin-5 deposition, cell spreading, and migration in keratinocytes. Tiam1-deficient keratinocytes cannot activate Rac upon alpha3beta1-mediated adhesion and cannot deposit their own LN5 substrate. Tiam1 or V12Rac1 rescues these defects.","method":"Tiam1 KO keratinocytes; Rac activation assay (GST-PAK pulldown); V12Rac1 rescue; wound healing/migration assay in vivo","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO cells with defined biochemical and functional phenotypes, V12Rac1 rescue, in vivo validation","pmids":["16330714"],"is_preprint":false},{"year":2005,"finding":"Tiam1 binds to IRSp53 (an adaptor/effector for Rac and Cdc42). Tiam1 directs IRSp53 preferentially to Rac signaling by enhancing its interaction with active Rac and the WAVE2 scaffold, promoting IRSp53 localization to lamellipodia over filopodia. IRSp53 depletion prevents Tiam1-dependent lamellipodia formation.","method":"Co-immunoprecipitation; IRSp53 siRNA depletion; subcellular localization by immunofluorescence; lamellipodia/filopodia morphology assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, siRNA rescue, localization studies, single lab","pmids":["15899863"],"is_preprint":false},{"year":2005,"finding":"Tiam1 is a Wnt-responsive gene: its expression is up-regulated in intestinal crypts by the canonical Wnt/APC pathway. Tiam1 deficiency in APC-mutant Min mice significantly reduces polyp formation and growth, but enhances malignant invasion, indicating Tiam1 promotes Wnt-driven tumor initiation/growth while restraining malignant conversion.","method":"Tiam1 KO × Min mouse cross; polyp counting; Tiam1 siRNA in human CRC cells; Wnt reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic cross with defined tumor phenotype, gene dosage effect, supported by cell-based experiments","pmids":["16249175"],"is_preprint":false},{"year":2006,"finding":"PAR-3 binds TIAM1 and spatially restricts it to dendritic spines in hippocampal neurons. Depletion of PAR-3 causes formation of multiple filopodia- and lamellipodia-like protrusions resembling activated Rac, indicating that PAR-3 limits TIAM1-mediated Rac-GTP levels to enable proper spine morphogenesis.","method":"PAR-3 RNAi; TIAM1 co-immunoprecipitation; spine morphology analysis in hippocampal neurons","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding, loss-of-function, specific morphological phenotype consistent with Rac activation","pmids":["16474385"],"is_preprint":false},{"year":2006,"finding":"Tiam1 interacts with the p21-Arc subunit of the Arp2/3 complex via its N-terminal PH domain and adjacent coiled-coil region. Tiam1 co-localizes with Arp2/3 at sites of actin polymerization. Deletion of the p21-Arc-binding domain impairs Tiam1 localization and Rac1 activation. Functionally active Tiam1 (but not GEF-deficient mutant) promotes Arp2/3 activation, revealing a self-amplifying Tiam1-Rac-Arp2/3 module.","method":"Yeast two-hybrid; co-immunoprecipitation; domain deletion; immunofluorescence co-localization; Rac1 activation assay; WASP inhibitor","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid confirmed by co-IP, domain mutants, GEF-dead mutant control, single lab","pmids":["16599904"],"is_preprint":false},{"year":2006,"finding":"TrkB directly binds Tiam1 and phosphorylates Tyr-829 in response to BDNF stimulation, leading to Rac1 activation and lamellipodia formation. A Y829F point mutation in Tiam1 blocks BDNF-induced morphological changes and neurite outgrowth.","method":"Co-immunoprecipitation; site-directed mutagenesis (Y829F); Rac1 activation assay; neurite outgrowth assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis at defined phosphorylation site with functional validation, single lab","pmids":["16801538"],"is_preprint":false},{"year":2007,"finding":"The Par-Tiam1 complex (Par3, Par6, PKCzeta, Tiam1) localizes to leading edges of migrating keratinocytes. Tiam1-deficient and Par3-depleted keratinocytes migrate randomly due to failure to maintain front-rear polarity. Par-Tiam1 stabilizes front-rear polarity by stabilizing microtubules; Tiam1 KO cells have unstable microtubules that impair directional but not random migration.","method":"Tiam1 KO and Par3 siRNA keratinocytes; chemotaxis assay; live cell imaging; immunoprecipitation; microtubule stability assay","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO and siRNA with defined polarity/migration phenotype, immunoprecipitation complex confirmed, microtubule mechanism defined","pmids":["17825562"],"is_preprint":false},{"year":2007,"finding":"EphB receptor activation by ephrinB1 induces tyrosine phosphorylation and recruitment of Tiam1 to EphB2-NMDAR complexes in a kinase-dependent manner. RNAi knockdown or dominant-negative Tiam1 blocks ephrinB1-induced dendritic spine formation, placing Tiam1 downstream of EphB in Rac1-dependent spine morphogenesis.","method":"Co-immunoprecipitation; tyrosine phosphorylation assay; RNAi knockdown; dominant-negative Tiam1; spine density analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct interaction, phosphorylation in complex, two independent loss-of-function approaches with morphological readout","pmids":["17440041"],"is_preprint":false},{"year":2008,"finding":"Paracingulin physically interacts with Tiam1 and GEF-H1 in vivo and in vitro, and is required for their efficient recruitment to epithelial junctions. Paracingulin depletion reduces Rac1 activity in a Tiam1-dependent manner during tight junction assembly and delays junction formation.","method":"Co-immunoprecipitation; in vitro binding; siRNA knockdown; immunofluorescence; Rac1 activity assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding plus co-IP confirmed, siRNA with functional readout, single lab","pmids":["18653465"],"is_preprint":false},{"year":2009,"finding":"Src phosphorylates Tiam1 on Y384, predominantly at adherens junctions. This creates a docking site for Grb2, leading to recruitment of the Grb2-Sos1 complex, ERK activation, and localized calpain-dependent degradation of Tiam1 at AJs, resulting in junction disassembly, cell migration, and EMT.","method":"Site-directed mutagenesis (Y384); mass spectrometry; co-immunoprecipitation; ERK activation assay; calpain inhibitor treatment; tumor tissue correlation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphorylation site mutagenesis with mechanistic cascade defined (Src→Y384→Grb2→ERK→calpain→Tiam1 degradation), single lab","pmids":["19285946"],"is_preprint":false},{"year":2009,"finding":"The Tiam1 PDZ domain adopts a canonical PDZ fold (crystal structure determined) and binds Syndecan1 C-terminal peptide. Syndecan1 is a physiological Tiam1 binding partner; the PDZ domain mediates cell-matrix adhesion and cell migration.","method":"X-ray crystallography; NMR chemical shift perturbation; equilibrium binding; mutagenesis; cell-matrix adhesion assay","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus NMR binding validation plus functional cell assay, single lab","pmids":["20361982"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of the Tiam1/2 PHCCEx domain reveals a single globular domain comprising a PH subdomain, antiparallel coiled-coil (CC), and novel three-helical Ex subdomain. Mutational analysis shows CC and Ex subdomains form a positively charged surface for protein binding. Two acidic motifs in binding partners (Motif-I in CD44, ephrinBs, NMDAR; Motif-II in Par3, JIP2) mediate PHCCEx interaction.","method":"X-ray crystallography; mutational binding analysis; peptide competition assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with mutational validation and identification of interaction motifs in multiple partners","pmids":["19893486"],"is_preprint":false},{"year":2010,"finding":"Tiam1 and Rac1 localize to centrosomes during prophase and prometaphase. Tiam1-Rac signaling retards centrosome separation and antagonizes Eg5 (kinesin-5). Tiam1-depleted cells escape monopolar arrest caused by Eg5 inhibition, display slower prometaphase transit, and show increased chromosome congression errors. This identifies Tiam1-Rac as the first antagonist of centrosome separation during prophase.","method":"Tiam1 siRNA depletion; centrosome separation quantification; Eg5 inhibitor (monastrol); chromosome congression analysis; immunofluorescence at centrosomes","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown, epistasis with Eg5 inhibitor, in vivo confirmation with Rac1-deficient cells","pmids":["20346677"],"is_preprint":false},{"year":2011,"finding":"The Tiam1 and Tiam2 PDZ domains have overlapping but distinct ligand specificities determined by four non-conserved residues in the S0 and S-2 pockets. A Tiam1 PDZ quadruple mutant acquires Tiam2 PDZ specificity, revealing the molecular determinants of ligand selectivity.","method":"Combinatorial peptide library screening; equilibrium binding assays; site-directed mutagenesis; double mutant cycle analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — combinatorial library, binding assays, and mutagenesis in single rigorous study","pmids":["21192692"],"is_preprint":false},{"year":2012,"finding":"Tiam1 interacts directly with talin, which links integrins to signaling. Tiam1 accumulates at adhesions dependent on talin and the PAR complex. Talin-Tiam1 and PAR complex interactions are required for adhesion-induced Rac1 activation, cell spreading, migration toward integrin substrates, and adhesion turnover.","method":"Co-immunoprecipitation; direct binding assay; Rac1 activation assay; cell spreading and migration assays; adhesion turnover measurement","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay, co-IP, functional rescue, single lab","pmids":["23071154"],"is_preprint":false},{"year":2012,"finding":"β2-syntrophin binds Tiam1 and promotes Tiam1-Rac activity at basal cell-cell junctions, generating an apicobasal Rac activity gradient. In contrast, apical Par-3 inhibits Tiam1-Rac activity. This gradient is required for optimal tight junction assembly and apical lumen formation.","method":"Co-immunoprecipitation; β2-syntrophin depletion; Rac activity assay; TJ assembly assay; lumen formation assay; constitutively active Rac targeting","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — interaction defined, loss-of-function with Rac activity gradient measured, functional consequence in lumen formation","pmids":["23103911"],"is_preprint":false},{"year":2012,"finding":"Tiam1 regulates the Wnt/Dvl/Rac1 pathway in midbrain dopaminergic neurons: Tiam1 interacts with Dvl, facilitates Dvl-Rac1 interaction, and is required for Wnt5a/Dvl-induced Rac1 activation. CK1 negatively regulates Tiam1-Dvl interaction. Tiam1 knockdown impairs DA neuron generation in ventral midbrain neurosphere cultures.","method":"Co-immunoprecipitation; Rac1 activation assay; Tiam1 knockdown; neurosphere cultures; DA neuron counting","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, Rac1 activation assay, knockdown with functional phenotype, single lab","pmids":["23109420"],"is_preprint":false},{"year":2013,"finding":"CADM1's cytoplasmic domain (type II PDZ-binding motif) directly interacts with the PDZ domain of Tiam1 in ATL cells. This interaction induces lamellipodia formation through Rac activation, promoting leukemic cell invasion.","method":"Amino acid alignment; direct binding assay; co-immunoprecipitation; lamellipodia morphology; Rac activation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction demonstrated, Rac activation assay, single lab","pmids":["20215110"],"is_preprint":false},{"year":2013,"finding":"NMDA receptor stimulation promotes oligodendrocyte precursor cell (OPC) migration via the Tiam1/Rac1/ERK signaling pathway. Tiam1 co-immunoprecipitates with NMDAR in OPCs. Pharmacological inhibition or shRNA knockdown of Tiam1 abolishes NMDAR-promoted migration.","method":"Co-immunoprecipitation; shRNA knockdown; Rac1/ERK activation assays; Boyden transwell and single-cell migration assays; brain slice culture","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, two loss-of-function approaches, defined signaling cascade, single lab","pmids":["24123220"],"is_preprint":false},{"year":2013,"finding":"SIRT1 and SIRT2 positively regulate TIAM1 activity and Rac1-GTP levels. SIRT1/2 inhibition leads to increased acetylation of TIAM1. SIRT1 maintains Dishevelled-1 (DVL1) levels to sustain a DVL1-TIAM1 scaffolding complex that promotes Rac activation. Diminished sirtuin activity disrupts DVL1-TIAM1 interaction.","method":"Co-immunoprecipitation; TIAM1 acetylation assay; Rac1 activity assay; SIRT1/2 inhibition; siRNA knockdown","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, acetylation, Rac activity assay, single lab","pmids":["24362520"],"is_preprint":false},{"year":2014,"finding":"HUWE1 E3 ubiquitin ligase ubiquitylates TIAM1 and targets it for proteasomal degradation, predominantly at cell-cell adhesions during HGF-induced scattering. Depletion of HUWE1 or mutation of the TIAM1 ubiquitylation site prevents TIAM1 degradation and antagonizes scattering and invasion. Simultaneous TIAM1 depletion restores migration in HUWE1-depleted cells.","method":"Ubiquitylation assay; proteasome inhibitor; HUWE1 knockdown; TIAM1 ubiquitylation site mutagenesis; scattering/invasion assay; lung cancer cell invasion assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — ubiquitylation site mutagenesis, epistasis rescue experiment, confirmed in human lung cancer cells","pmids":["25543140"],"is_preprint":false},{"year":2014,"finding":"Phosphatidylinositol 5-phosphate (PtdIns5P) binds the DH-PH domains of Tiam1 and activates its GEF activity. In a reconstituted assay with membrane-anchored Rac1-His and PtdIns5P-containing liposomes, intrinsic Tiam1 DH-PH activity is enhanced by the PtdIns5P-enriched environment. This pathway is operative in receptor tyrosine kinase activation, bacterial IpgD expression, and NPM-ALK+ lymphoma invasion.","method":"Lipid-binding assay; in vitro GEF activity reconstitution with liposomes; Rac1-His membrane anchoring assay; cell invasion assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro assay with defined lipid-protein interaction and functional GEF activity measurement","pmids":["24905281"],"is_preprint":false},{"year":2015,"finding":"AKT (downstream of EGFR/PI3K) phosphorylates TIAM1 at consensus phosphorylation sites, facilitating interaction with scaffold proteins 14-3-3 and increasing TIAM1 protein stability. TIAM1 is subsequently dephosphorylated and destabilized by PP2A, defining a bidirectional phosphorylation/dephosphorylation mechanism controlling TIAM1 stability and EGFR-driven Rac1 activation.","method":"AKT in vitro kinase assay; 14-3-3 co-immunoprecipitation; PP2A inhibitor/overexpression; protein stability assay; TIAM1 knockdown","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay, co-IP with 14-3-3, PP2A dephosphorylation validated, single lab","pmids":["25746002"],"is_preprint":false},{"year":2015,"finding":"The CUL3-KBTBD6/KBTBD7 ubiquitin ligase complex mediates ubiquitylation and proteasomal degradation of TIAM1. KBTBD6/7 employ ATG8-family-interacting motifs to bind GABARAP proteins. TIAM1 ubiquitylation depends on its binding to GABARAP proteins on vesicles, thereby spatially restricting membrane-associated TIAM1 and RAC1 signaling.","method":"Ubiquitylation assay; KBTBD6/7 knockdown; GABARAP co-immunoprecipitation; proteasome inhibitor; Rac1 activity assay; actin morphology analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — ubiquitylation assay, defined E3 complex, GABARAP-dependent mechanism, multiple functional readouts","pmids":["25684205"],"is_preprint":false},{"year":2015,"finding":"Cdk1 phosphorylates Tiam1 on S1466 during mitosis. This phosphorylation is required for activation of group I p21-activated kinases (Pak1 and Pak2) on centrosomes in prophase. Pak1 and Pak2 counteract centrosome separation downstream of Tiam1, and Pak1/2 depletion allows cells to escape monopolar arrest by Eg5 inhibition.","method":"Site-directed mutagenesis (S1466); in vitro Cdk1 kinase assay; centrosome Pak activation assay; siRNA knockdown of Pak1/2; monopolar arrest assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay, site-directed mutagenesis at defined Cdk1 site, downstream kinase epistasis, single lab","pmids":["26078008"],"is_preprint":false},{"year":2016,"finding":"Tiam1 and Rac1 form a complex with the transcription factor RORγt in the nucleus of Th17 cells and together bind and activate the Il17a promoter. Tiam1 genetic deficiency weakens IL-17A expression and attenuates experimental autoimmune encephalomyelitis (EAE).","method":"Co-immunoprecipitation of nuclear Tiam1-Rac1-RORγt complex; ChIP assay at Il17 promoter; Tiam1 KO mice; EAE model; pharmacological Rac1 inhibition","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of nuclear complex, ChIP, in vivo KO phenotype, single lab","pmids":["27725632"],"is_preprint":false},{"year":2017,"finding":"TIAM1 antagonizes TAZ/YAP by two spatially distinct mechanisms: (1) in the cytoplasm, TIAM1 localizes to the destruction complex and promotes TAZ degradation by enhancing its interaction with βTrCP; (2) in the nucleus, TIAM1 suppresses TAZ/YAP interaction with TEAD transcription factors, inhibiting EMT-related gene expression and CRC cell invasion.","method":"Nuclear/cytoplasmic fractionation; co-immunoprecipitation of TIAM1 with destruction complex and βTrCP; TEAD interaction assay; TAZ degradation assay; CRC cell invasion assay","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — two mechanistically distinct compartment-specific interactions defined, multiple biochemical assays, functional invasion readout","pmids":["28416184"],"is_preprint":false},{"year":2018,"finding":"EndoA3 (endophilin A3) binds TIAM1 directly, and this interaction competes with EndoA3 membrane binding. When EndoA3-membrane interaction is disrupted, TIAM1 binding is favored, leading to TIAM1 and small GTPase activation and increased cell motility/metastasis in vivo.","method":"Direct binding assay (EndoA3-TIAM1); competition with membrane liposomes; GTPase activation assay; in vivo metastasis model in zebrafish","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding, competition assay, in vivo validation, single lab","pmids":["29920278"],"is_preprint":false},{"year":2022,"finding":"Tiam1 orchestrates synaptic structural and functional plasticity in anterior cingulate cortex (ACC) neurons via actin cytoskeleton reorganization and synaptic NMDAR stabilization. Tiam1-mediated synaptic plasticity drives ACC hyperactivity underlying chronic pain-induced depressive-like behaviors. Ketamine blocks Tiam1-mediated maladaptive synaptic plasticity to produce antidepressant-like effects.","method":"Tiam1 conditional KO; electrophysiology; spine morphology imaging; actin dynamics assay; NMDAR surface expression; chronic pain mouse models; behavioral assays","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with electrophysiological and morphological phenotypes, pharmacological intervention, single lab","pmids":["36519542"],"is_preprint":false},{"year":2022,"finding":"Loss-of-function variants in TIAM1 (bi-allelic missense) cause developmental delay, intellectual disability, and seizures. In Drosophila, loss of the ortholog still life (sif) reduces survival, causes climbing defects and seizures. Human TIAM1 reference cDNA partially rescues sif loss-of-function phenotypes; patient variants show reduced rescue ability confirming partial loss of function.","method":"Human genetics (bi-allelic variants in patients); Drosophila sif KO; in vivo rescue with TIAM1 reference vs. patient variant cDNAs; ectopic expression toxicity assay","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — human genetics validated by Drosophila ortholog rescue experiments with allele-level functional analysis","pmids":["35240055"],"is_preprint":false},{"year":2022,"finding":"YAP1-TEAD4 transcriptionally activates TIAM1 expression by binding to an enhancer region of the TIAM1 gene. TIAM1 upregulation increases RAC1 activity and induces invadopodia formation in breast cancer cells.","method":"ChIP assay for TEAD4 at TIAM1 enhancer; YAP1 knockdown/overexpression; TIAM1 expression measurement; RAC1 activity assay; invadopodia assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP defining transcriptional activation, functional readout (RAC1 activity, invadopodia), single lab","pmids":["35773411"],"is_preprint":false}],"current_model":"TIAM1 is a multi-domain Rac1-specific guanine nucleotide exchange factor (GEF) whose DH-PH catalytic module is activated downstream of diverse receptors (NMDAR, EphB/EphA, TrkB, EGFR, integrins, S1P1) and signaling lipids (PtdIns(3,4,5)P3, PtdIns5P); its activity is positively regulated by CaMKII-mediated phosphorylation of defined sites (enhanced GEF activity), Cdk1-mediated phosphorylation at S1466 (centrosomal Pak activation during mitosis), and TrkB-mediated phosphorylation at Y829, and negatively regulated by Src-mediated Y384 phosphorylation that creates a Grb2 docking site leading to ERK-calpain-dependent localized degradation, as well as by ubiquitin-mediated proteasomal degradation via HUWE1 and CUL3-KBTBD6/7 E3 ligases (the latter requiring GABARAP-mediated membrane recruitment); TIAM1 is anchored to functionally distinct subcellular compartments through its PDZ domain (Syndecan1), PHn-CC-Ex domain (Par3, CD44, NMDAR, ephrinBs), and N-terminal PH domain (phosphoinositides and Arp2/3 complex p21-Arc subunit), and in the Par3-Par6-aPKC polarity complex it spatially restricts Rac1 activation to control epithelial tight junction assembly, apical-basal polarity, axon specification, dendritic spine morphogenesis, and front-rear polarity in migrating cells; TIAM1 also functions non-canonically in the nucleus where it forms a complex with Rac1 and RORγt to drive Il17a transcription in Th17 cells, and antagonizes TAZ/YAP by promoting TAZ degradation at the cytoplasmic destruction complex and blocking TAZ/YAP-TEAD interaction in the nucleus."},"narrative":{"mechanistic_narrative":"TIAM1 is a Rac1-specific guanine nucleotide exchange factor (GEF) that couples diverse upstream receptors and lipid signals to localized Rac1-driven actin remodeling, governing cell adhesion, polarity, migration, and neuronal morphogenesis [PMID:7753201, PMID:9832565]. Its catalytic output toward Rac1 was first defined biochemically in vitro and confirmed by Rac1-dependent membrane ruffling in fibroblasts, where N-terminal truncation unmasks oncogenic transforming activity that is phenocopied by activated Rac1 [PMID:7753201, PMID:8570171]. TIAM1 acts as a direct Ras effector through a Ras-binding domain, synergizing with activated Ras to generate Rac-GTP independently of PI3K, and Tiam1-deficient mice are resistant to Ras-induced skin tumorigenesis, establishing it as a physiological proto-oncogene [PMID:12134164, PMID:12075356]. GEF activity is gated by phosphoinositides binding the N-terminal PH domain — PtdIns(3,4,5)P3 and PtdIns5P stimulate exchange activity — and by phosphorylation: CaMKII and TrkB-mediated Y829 phosphorylation enhance activity, Cdk1 phosphorylation of S1466 drives centrosomal Pak activation in mitosis, while Src phosphorylation of Y384 creates a Grb2 docking site triggering ERK/calpain-dependent local degradation [PMID:10998360, PMID:24905281, PMID:10212259, PMID:16801538, PMID:26078008, PMID:19285946]. TIAM1 levels are further controlled by HUWE1 and CUL3-KBTBD6/7 (the latter requiring GABARAP-mediated membrane recruitment) ubiquitin-dependent degradation [PMID:25543140, PMID:25684205]. Spatial control of Rac1 activation is achieved through compartment-specific anchoring: the PHn-CC-Ex domain binds CD44, NMDAR, ephrinBs, and Par3, the PDZ domain binds Syndecan1 and CADM1, and the N-PH domain binds the Arp2/3 p21-Arc subunit, forming a self-amplifying Tiam1-Rac-Arp2/3 module [PMID:19893486, PMID:20361982, PMID:16599904]. Within the Par3-Par6-aPKC polarity complex TIAM1 restricts Rac1 activation to control tight junction assembly, apical-basal and front-rear polarity, axon specification, and dendritic spine morphogenesis [PMID:15723052, PMID:15723051, PMID:15721239, PMID:17825562]. Non-canonically, TIAM1 forms a nuclear complex with Rac1 and RORγt to drive Il17a transcription in Th17 cells and antagonizes TAZ/YAP by promoting TAZ degradation and blocking TAZ/YAP-TEAD interaction [PMID:27725632, PMID:28416184]. Bi-allelic loss-of-function TIAM1 variants cause developmental delay, intellectual disability, and seizures, validated by rescue of the Drosophila sif ortholog [PMID:35240055].","teleology":[{"year":1995,"claim":"Established TIAM1's core biochemical identity — whether it was an enzyme acting on Rho GTPases — by showing it is a Rac-preferential GEF whose activity drives actin remodeling and oncogenic transformation.","evidence":"In vitro GDS assay and dominant-negative Rac1 epistasis in fibroblasts; N-terminal truncation focus formation assay in NIH3T3","pmids":["7753201","8570171"],"confidence":"High","gaps":["Did not define the upstream receptors activating Tiam1","Did not resolve how the N-terminus autoinhibits the catalytic module"]},{"year":1997,"claim":"Connected TIAM1's GEF activity to epithelial biology by showing it localizes to adherens junctions and promotes E-cadherin adhesion while suppressing invasion, framing context-dependent control of motility versus adhesion.","evidence":"Ectopic expression, immunolocalization, and HGF scattering/invasion assays in MDCK cells; PKC-dependent threonine phosphorylation assays","pmids":["9367959","9407095"],"confidence":"High","gaps":["Mechanism switching Tiam1 between junction stabilization and migration not yet defined","Functional consequence of PKC phosphorylation on GEF activity unresolved"]},{"year":1998,"claim":"Resolved how upstream signals reach TIAM1 by placing PI3-kinase upstream and showing the Tiam1/Rac response is substrate (ECM)-dependent, with distinct localization in motile versus non-motile cells.","evidence":"Substrate-dependent migration/adhesion assays, PI3K inhibition epistasis, GST-PAK pulldowns, and immunolocalization in epithelial cells","pmids":["9832565"],"confidence":"High","gaps":["Direct PI3K-product engagement by Tiam1 not yet shown biochemically"]},{"year":1999,"claim":"Defined post-translational positive regulation by showing CaMKII phosphorylation enhances Tiam1 exchange activity and PP1 reverses it, linking calcium signaling to Rac activation.","evidence":"In vitro CaMKII and PP1 assays with nucleotide exchange readout; intracellular calcium manipulation","pmids":["10212259"],"confidence":"High","gaps":["Specific phosphosites not mapped in this study","Magnitude of activation modest (~2-fold)"]},{"year":2000,"claim":"Identified the membrane and lipid inputs that activate TIAM1 — direct phosphoinositide binding by the N-PH domain (PtdIns(3,4,5)P3 preferred) and physical scaffolding by CD44v3 and ankyrin — explaining how PI3K and adhesion receptors engage the GEF.","evidence":"Lipid-binding and in vitro GEF assays with domain mutants; co-IP, Scatchard binding, and invasion assays for CD44 and ankyrin","pmids":["10998360","10636882","10893266"],"confidence":"High","gaps":["How lipid binding mechanistically relieves autoinhibition not structurally defined"]},{"year":2002,"claim":"Placed TIAM1 as a direct Ras effector and demonstrated its in vivo requirement for Ras-driven tumorigenesis, connecting its GEF biochemistry to oncogenic signaling, while also showing scaffold (JIP2/IB2) association directs MAPK pathway specificity.","evidence":"RBD pulldown of GTP-Ras with PI3K-independent Rac-GTP epistasis; Tiam1 KO mice in DMBA/TPA skin model; yeast two-hybrid and kinase assays for JIP2","pmids":["12134164","12075356","12024021"],"confidence":"High","gaps":["How Ras-binding integrates with lipid/scaffold inputs unresolved","Tissue-specificity of Tiam1 oncogenic requirement not generalized"]},{"year":2005,"claim":"Established TIAM1 as the spatially restricted Rac activator within the Par3-Par6-aPKC polarity complex and as the receptor-coupled GEF in neurons, controlling tight junctions, lamellipodia, axon specification, and dendritic/spine morphogenesis.","evidence":"Co-IP, complex reconstitution, genetic epistasis (Par3/Tiam1/Rac), and morphological assays in MDCK cells, hippocampal neurons, and dendrites; NMDAR co-IP and phosphorylation","pmids":["15723052","15723051","15721239","16330714","15899863"],"confidence":"High","gaps":["How Par3 binding biochemically restrains GEF activity not fully defined","Cross-talk between integrin and polarity-complex anchoring unresolved"]},{"year":2006,"claim":"Defined receptor-specific activation modes — TrkB-mediated Y829 phosphorylation and EphB-NMDAR recruitment — and a self-amplifying Tiam1-Rac-Arp2/3 module via N-PH/p21-Arc binding, linking TIAM1 to growth-factor and Eph signaling in neurons.","evidence":"Y829F mutagenesis with neurite outgrowth; EphB2-NMDAR co-IP and spine assays; yeast two-hybrid and co-IP for p21-Arc with GEF-dead controls","pmids":["16801538","17440041","16599904"],"confidence":"High","gaps":["Quantitative contribution of each receptor input in vivo not partitioned"]},{"year":2009,"claim":"Provided structural and degradative regulatory detail — PDZ and PHCCEx domain crystal structures defining partner-binding surfaces and motifs, and the Src→Y384→Grb2→ERK→calpain cascade driving localized Tiam1 degradation at junctions.","evidence":"X-ray crystallography of PDZ and PHCCEx domains with mutational/peptide validation; Y384 mutagenesis, mass spectrometry, and calpain-inhibitor assays","pmids":["20361982","19893486","19285946"],"confidence":"High","gaps":["Structure of the full-length autoinhibited GEF not determined"]},{"year":2010,"claim":"Uncovered a mitotic role by showing Tiam1-Rac localizes to centrosomes and antagonizes centrosome separation and Eg5, expanding TIAM1 function beyond interphase actin control.","evidence":"Tiam1 siRNA with centrosome separation quantification, monastrol/Eg5 epistasis, and chromosome congression analysis","pmids":["20346677"],"confidence":"High","gaps":["Mitotic activator of centrosomal Tiam1 not identified in this study (resolved 2015)"]},{"year":2012,"claim":"Refined spatial Rac control by defining talin, β2-syntrophin, and Dvl interactions that establish adhesion-site recruitment and an apicobasal Rac activity gradient opposing apical Par3.","evidence":"Co-IP and direct binding, depletion with Rac activity gradient measurement, and lumen/junction/migration assays in epithelial and neuronal systems","pmids":["23071154","23103911","23109420"],"confidence":"Medium","gaps":["Single-lab interaction data for several partners without reciprocal structural mapping","How opposing apical/basal inputs are integrated dynamically unresolved"]},{"year":2014,"claim":"Established ubiquitin- and lipid-dependent control of TIAM1 abundance and localization via HUWE1 and CUL3-KBTBD6/7, the latter requiring GABARAP-mediated vesicle recruitment, plus acetylation control by SIRT1/2.","evidence":"Ubiquitylation site mutagenesis and epistasis rescue (HUWE1); KBTBD6/7 knockdown with GABARAP co-IP; acetylation and Rac activity assays (SIRT1/2)","pmids":["25543140","25684205","24362520","24905281"],"confidence":"High","gaps":["Interplay between competing E3 ligases in different compartments not resolved","Whether PtdIns5P activation and degradation occur on the same vesicle pools unknown"]},{"year":2015,"claim":"Defined the mitotic activator and additional stability control — Cdk1 phosphorylation of S1466 driving centrosomal Pak1/2 activation, and AKT/14-3-3/PP2A bidirectional control of TIAM1 stability downstream of EGFR.","evidence":"S1466 mutagenesis with in vitro Cdk1 assay and Pak epistasis; AKT kinase assay, 14-3-3 co-IP, and PP2A stability assays","pmids":["26078008","25746002"],"confidence":"High","gaps":["How Cdk1 site phosphorylation couples to Pak activation biochemically not detailed"]},{"year":2017,"claim":"Revealed non-canonical, compartment-segregated functions — nuclear Tiam1-Rac1-RORγt driving Il17a transcription, and dual cytoplasmic/nuclear antagonism of TAZ/YAP — establishing transcriptional and Hippo-pathway roles distinct from cytoskeletal GEF activity.","evidence":"Nuclear complex co-IP and ChIP with Tiam1 KO EAE model; fractionation, βTrCP/destruction-complex and TEAD interaction assays with CRC invasion readouts","pmids":["27725632","28416184"],"confidence":"Medium","gaps":["Whether nuclear functions require GEF catalytic activity not fully dissected","Single-lab evidence for each non-canonical mechanism"]},{"year":2022,"claim":"Linked TIAM1 to human disease and complex physiology — bi-allelic loss-of-function variants causing developmental delay/intellectual disability/seizures, synaptic plasticity in chronic pain-induced depression, and YAP1-TEAD4 transcriptional activation of TIAM1 in cancer invasion.","evidence":"Human genetics with Drosophila sif rescue; conditional KO with electrophysiology/behavior; ChIP and invadopodia assays","pmids":["35240055","36519542","35773411"],"confidence":"Medium","gaps":["Mechanistic basis of seizure/ID phenotype at the neuronal circuit level incomplete","Reciprocal YAP-TIAM1 regulation (TIAM1 inhibits TAZ/YAP yet YAP1 activates TIAM1) not reconciled"]},{"year":null,"claim":"How the many competing inputs (lipids, receptor phosphorylation, scaffolds, E3 ligases, acetylation) are integrated on a single autoinhibited full-length TIAM1 molecule to produce spatially and temporally precise Rac1 activation remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length structure showing the autoinhibited-to-active transition","Quantitative hierarchy among activating versus degradative inputs unknown","Mechanistic relationship between cytoskeletal GEF and nuclear transcriptional roles undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,5,7,8,39]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[8,39]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[15,16,24,26]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[43,44]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,4,8,18]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[9,22,24]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[30,42]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[43,44]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[44]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,10,23,25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,20,38,44,48]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[30,42]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[38,41]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9,17,25,46]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[43]}],"complexes":["Par3-Par6-aPKC polarity complex","Tiam1-Rac1-RORγt nuclear complex","EphB2-NMDAR complex","Wnt destruction complex"],"partners":["RAC1","PARD3","CD44","HRAS","TRKB","SDC1","GABARAP","DVL1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13009","full_name":"Rho guanine nucleotide exchange factor TIAM1","aliases":["T-lymphoma invasion and metastasis-inducing protein 1","TIAM-1"],"length_aa":1591,"mass_kda":177.5,"function":"Guanyl-nucleotide exchange factor that activates RHO-like proteins and connects extracellular signals to cytoskeletal activities. Activates RAC1, CDC42, and to a lesser extent RHOA and their downstream signaling to regulate processes like cell adhesion and cell migration","subcellular_location":"Cell junction; Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q13009/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TIAM1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000156299","cell_line_id":"CID000583","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"ILF3","stoichiometry":0.2},{"gene":"PHKG2","stoichiometry":0.2},{"gene":"WNK1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000583","total_profiled":1310},"omim":[{"mim_id":"619908","title":"NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND SEIZURES; NEDLDS","url":"https://www.omim.org/entry/619908"},{"mim_id":"617739","title":"KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 7; KBTBD7","url":"https://www.omim.org/entry/617739"},{"mim_id":"617738","title":"KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 6; KBTBD6","url":"https://www.omim.org/entry/617738"},{"mim_id":"606745","title":"PAR3 FAMILY CELL POLARITY REGULATOR; PARD3","url":"https://www.omim.org/entry/606745"},{"mim_id":"604709","title":"T-CELL LYMPHOMA INVASION AND METASTASIS 2; TIAM2","url":"https://www.omim.org/entry/604709"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cell Junctions","reliability":"Supported"},{"location":"Nuclear membrane","reliability":"Additional"},{"location":"Cytokinetic bridge","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":264.4}],"url":"https://www.proteinatlas.org/search/TIAM1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q13009","domains":[{"cath_id":"2.30.29.30","chopping":"433-678","consensus_level":"high","plddt":86.0562,"start":433,"end":678},{"cath_id":"2.30.42.10","chopping":"766-927","consensus_level":"medium","plddt":83.1175,"start":766,"end":927},{"cath_id":"1.20.900.10","chopping":"1036-1252","consensus_level":"medium","plddt":92.7147,"start":1036,"end":1252},{"cath_id":"2.30.29.30","chopping":"1253-1309_1328-1403","consensus_level":"medium","plddt":85.7565,"start":1253,"end":1403}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13009","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13009-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13009-F1-predicted_aligned_error_v6.png","plddt_mean":58.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TIAM1","jax_strain_url":"https://www.jax.org/strain/search?query=TIAM1"},"sequence":{"accession":"Q13009","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13009.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13009/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13009"}},"corpus_meta":[{"pmid":"9832565","id":"PMC_9832565","title":"Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9832565","citation_count":589,"is_preprint":false},{"pmid":"7753201","id":"PMC_7753201","title":"A role for Rac in Tiam1-induced membrane ruffling and invasion.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7753201","citation_count":507,"is_preprint":false},{"pmid":"9367959","id":"PMC_9367959","title":"Inhibition of invasion of epithelial cells by Tiam1-Rac signaling.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9367959","citation_count":394,"is_preprint":false},{"pmid":"15723052","id":"PMC_15723052","title":"Par-3 controls tight junction assembly through the Rac exchange factor Tiam1.","date":"2005","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15723052","citation_count":382,"is_preprint":false},{"pmid":"15723051","id":"PMC_15723051","title":"PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1.","date":"2005","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15723051","citation_count":313,"is_preprint":false},{"pmid":"15721239","id":"PMC_15721239","title":"The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines.","date":"2005","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15721239","citation_count":312,"is_preprint":false},{"pmid":"12075356","id":"PMC_12075356","title":"Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12075356","citation_count":306,"is_preprint":false},{"pmid":"12134164","id":"PMC_12134164","title":"Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12134164","citation_count":267,"is_preprint":false},{"pmid":"10636882","id":"PMC_10636882","title":"CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10636882","citation_count":241,"is_preprint":false},{"pmid":"16195373","id":"PMC_16195373","title":"Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.","date":"2005","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16195373","citation_count":238,"is_preprint":false},{"pmid":"20826792","id":"PMC_20826792","title":"miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20826792","citation_count":232,"is_preprint":false},{"pmid":"16474385","id":"PMC_16474385","title":"The polarity protein PAR-3 and TIAM1 cooperate in dendritic spine morphogenesis.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16474385","citation_count":178,"is_preprint":false},{"pmid":"12024021","id":"PMC_12024021","title":"Interaction of Rac exchange factors Tiam1 and Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12024021","citation_count":163,"is_preprint":false},{"pmid":"17440041","id":"PMC_17440041","title":"The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17440041","citation_count":161,"is_preprint":false},{"pmid":"17825562","id":"PMC_17825562","title":"The Par-Tiam1 complex controls persistent migration by stabilizing microtubule-dependent front-rear polarity.","date":"2007","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/17825562","citation_count":151,"is_preprint":false},{"pmid":"11264310","id":"PMC_11264310","title":"Evidence for the involvement of Tiam1 in axon formation.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11264310","citation_count":150,"is_preprint":false},{"pmid":"10212259","id":"PMC_10212259","title":"Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10212259","citation_count":145,"is_preprint":false},{"pmid":"14999151","id":"PMC_14999151","title":"The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression.","date":"2004","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/14999151","citation_count":135,"is_preprint":false},{"pmid":"16801538","id":"PMC_16801538","title":"TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16801538","citation_count":120,"is_preprint":false},{"pmid":"15138270","id":"PMC_15138270","title":"The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15138270","citation_count":110,"is_preprint":false},{"pmid":"23886165","id":"PMC_23886165","title":"miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.","date":"2013","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/23886165","citation_count":109,"is_preprint":false},{"pmid":"10893266","id":"PMC_10893266","title":"Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10893266","citation_count":109,"is_preprint":false},{"pmid":"8570171","id":"PMC_8570171","title":"Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8570171","citation_count":106,"is_preprint":false},{"pmid":"25654811","id":"PMC_25654811","title":"By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25654811","citation_count":105,"is_preprint":false},{"pmid":"17428964","id":"PMC_17428964","title":"HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/Rac-dependent inhibition of the Rho pathway.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17428964","citation_count":103,"is_preprint":false},{"pmid":"16249175","id":"PMC_16249175","title":"The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16249175","citation_count":103,"is_preprint":false},{"pmid":"23142282","id":"PMC_23142282","title":"MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.","date":"2012","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/23142282","citation_count":98,"is_preprint":false},{"pmid":"10998360","id":"PMC_10998360","title":"Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10998360","citation_count":97,"is_preprint":false},{"pmid":"10229192","id":"PMC_10229192","title":"Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10229192","citation_count":95,"is_preprint":false},{"pmid":"20444703","id":"PMC_20444703","title":"miR-10b targets Tiam1: implications for Rac activation and carcinoma migration.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20444703","citation_count":90,"is_preprint":false},{"pmid":"17086355","id":"PMC_17086355","title":"Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells.","date":"2006","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/17086355","citation_count":87,"is_preprint":false},{"pmid":"16330714","id":"PMC_16330714","title":"The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16330714","citation_count":86,"is_preprint":false},{"pmid":"15899863","id":"PMC_15899863","title":"Tiam1-IRSp53 complex formation directs specificity of rac-mediated actin cytoskeleton regulation.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15899863","citation_count":85,"is_preprint":false},{"pmid":"14988728","id":"PMC_14988728","title":"Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14988728","citation_count":83,"is_preprint":false},{"pmid":"18653465","id":"PMC_18653465","title":"Paracingulin regulates the activity of Rac1 and RhoA GTPases by recruiting Tiam1 and GEF-H1 to epithelial junctions.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18653465","citation_count":82,"is_preprint":false},{"pmid":"16650994","id":"PMC_16650994","title":"Tiam1 takes PARt in cell polarity.","date":"2006","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16650994","citation_count":81,"is_preprint":false},{"pmid":"19139083","id":"PMC_19139083","title":"The Rac activator Tiam1 controls efficient T-cell trafficking and route of transendothelial migration.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19139083","citation_count":81,"is_preprint":false},{"pmid":"19095647","id":"PMC_19095647","title":"Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19095647","citation_count":81,"is_preprint":false},{"pmid":"24308970","id":"PMC_24308970","title":"The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.","date":"2013","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24308970","citation_count":80,"is_preprint":false},{"pmid":"24551096","id":"PMC_24551096","title":"MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24551096","citation_count":80,"is_preprint":false},{"pmid":"25746002","id":"PMC_25746002","title":"An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25746002","citation_count":78,"is_preprint":false},{"pmid":"19285946","id":"PMC_19285946","title":"SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19285946","citation_count":78,"is_preprint":false},{"pmid":"28416184","id":"PMC_28416184","title":"TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.","date":"2017","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/28416184","citation_count":77,"is_preprint":false},{"pmid":"9407095","id":"PMC_9407095","title":"Lysophosphatidic acid induces threonine phosphorylation of Tiam1 in Swiss 3T3 fibroblasts via activation of protein kinase C.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9407095","citation_count":74,"is_preprint":false},{"pmid":"25032858","id":"PMC_25032858","title":"miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25032858","citation_count":73,"is_preprint":false},{"pmid":"7731688","id":"PMC_7731688","title":"Sequence of the human invasion-inducing TIAM1 gene, its conservation in evolution and its expression in tumor cell lines of different tissue origin.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7731688","citation_count":73,"is_preprint":false},{"pmid":"25684205","id":"PMC_25684205","title":"CUL3-KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25684205","citation_count":71,"is_preprint":false},{"pmid":"18246045","id":"PMC_18246045","title":"Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.","date":"2008","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/18246045","citation_count":70,"is_preprint":false},{"pmid":"24905281","id":"PMC_24905281","title":"Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24905281","citation_count":69,"is_preprint":false},{"pmid":"15340013","id":"PMC_15340013","title":"The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15340013","citation_count":65,"is_preprint":false},{"pmid":"11054665","id":"PMC_11054665","title":"Tiam1 mutations in human renal-cell carcinomas.","date":"2000","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11054665","citation_count":64,"is_preprint":false},{"pmid":"24501217","id":"PMC_24501217","title":"Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24501217","citation_count":64,"is_preprint":false},{"pmid":"30890693","id":"PMC_30890693","title":"TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30890693","citation_count":63,"is_preprint":false},{"pmid":"20215110","id":"PMC_20215110","title":"CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20215110","citation_count":62,"is_preprint":false},{"pmid":"23071154","id":"PMC_23071154","title":"Tiam1 interaction with the PAR complex promotes talin-mediated Rac1 activation during polarized cell migration.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23071154","citation_count":61,"is_preprint":false},{"pmid":"30722989","id":"PMC_30722989","title":"Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30722989","citation_count":60,"is_preprint":false},{"pmid":"26821678","id":"PMC_26821678","title":"The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.","date":"2016","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/26821678","citation_count":56,"is_preprint":false},{"pmid":"25543140","id":"PMC_25543140","title":"HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25543140","citation_count":56,"is_preprint":false},{"pmid":"36070054","id":"PMC_36070054","title":"ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.","date":"2022","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36070054","citation_count":56,"is_preprint":false},{"pmid":"36519542","id":"PMC_36519542","title":"TIAM1-mediated synaptic plasticity underlies comorbid depression-like and ketamine antidepressant-like actions in chronic pain.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36519542","citation_count":55,"is_preprint":false},{"pmid":"18006851","id":"PMC_18006851","title":"16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18006851","citation_count":55,"is_preprint":false},{"pmid":"25739101","id":"PMC_25739101","title":"MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25739101","citation_count":53,"is_preprint":false},{"pmid":"17219408","id":"PMC_17219408","title":"Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17219408","citation_count":51,"is_preprint":false},{"pmid":"24362520","id":"PMC_24362520","title":"The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24362520","citation_count":50,"is_preprint":false},{"pmid":"20346677","id":"PMC_20346677","title":"Tiam1-Rac signaling counteracts Eg5 during bipolar spindle assembly to facilitate chromosome congression.","date":"2010","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/20346677","citation_count":48,"is_preprint":false},{"pmid":"27725632","id":"PMC_27725632","title":"Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27725632","citation_count":47,"is_preprint":false},{"pmid":"16599904","id":"PMC_16599904","title":"Interaction between Tiam1 and the Arp2/3 complex links activation of Rac to actin polymerization.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16599904","citation_count":47,"is_preprint":false},{"pmid":"22469921","id":"PMC_22469921","title":"Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells.","date":"2012","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22469921","citation_count":47,"is_preprint":false},{"pmid":"23103911","id":"PMC_23103911","title":"β2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity.","date":"2012","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23103911","citation_count":46,"is_preprint":false},{"pmid":"23307871","id":"PMC_23307871","title":"Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.","date":"2013","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23307871","citation_count":46,"is_preprint":false},{"pmid":"24123220","id":"PMC_24123220","title":"NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/24123220","citation_count":45,"is_preprint":false},{"pmid":"20802514","id":"PMC_20802514","title":"The role of fibroblast Tiam1 in tumor cell invasion and metastasis.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20802514","citation_count":44,"is_preprint":false},{"pmid":"17132223","id":"PMC_17132223","title":"Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line.","date":"2006","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17132223","citation_count":44,"is_preprint":false},{"pmid":"25967961","id":"PMC_25967961","title":"Tiam1-Rac1 Axis Promotes Activation of p38 MAP Kinase in the Development of Diabetic Retinopathy: Evidence for a Requisite Role for Protein Palmitoylation.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25967961","citation_count":43,"is_preprint":false},{"pmid":"38357802","id":"PMC_38357802","title":"S-Nitrosylation of Septin2 Exacerbates Aortic Aneurysm and Dissection by Coupling the TIAM1-RAC1 Axis in Macrophages.","date":"2024","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/38357802","citation_count":42,"is_preprint":false},{"pmid":"26078008","id":"PMC_26078008","title":"Cdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26078008","citation_count":42,"is_preprint":false},{"pmid":"20361982","id":"PMC_20361982","title":"The Tiam1 PDZ domain couples to Syndecan1 and promotes cell-matrix adhesion.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20361982","citation_count":41,"is_preprint":false},{"pmid":"29277502","id":"PMC_29277502","title":"Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/β-catenin signaling.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29277502","citation_count":41,"is_preprint":false},{"pmid":"23109420","id":"PMC_23109420","title":"Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23109420","citation_count":41,"is_preprint":false},{"pmid":"25973950","id":"PMC_25973950","title":"The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25973950","citation_count":40,"is_preprint":false},{"pmid":"24112471","id":"PMC_24112471","title":"EphA2 signaling following endocytosis: role of Tiam1.","date":"2013","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/24112471","citation_count":38,"is_preprint":false},{"pmid":"23322732","id":"PMC_23322732","title":"Balanced Tiam1-rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells.","date":"2013","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/23322732","citation_count":37,"is_preprint":false},{"pmid":"22573407","id":"PMC_22573407","title":"Tiam1 is associated with hepatocellular carcinoma metastasis.","date":"2012","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22573407","citation_count":36,"is_preprint":false},{"pmid":"24350867","id":"PMC_24350867","title":"5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation.","date":"2014","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/24350867","citation_count":32,"is_preprint":false},{"pmid":"21192692","id":"PMC_21192692","title":"Distinct ligand specificity of the Tiam1 and Tiam2 PDZ domains.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21192692","citation_count":32,"is_preprint":false},{"pmid":"17376711","id":"PMC_17376711","title":"Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer.","date":"2007","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/17376711","citation_count":31,"is_preprint":false},{"pmid":"28202288","id":"PMC_28202288","title":"Tiam1/Vav2-Rac1 axis: A tug-of-war between islet function and dysfunction.","date":"2017","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28202288","citation_count":30,"is_preprint":false},{"pmid":"15295645","id":"PMC_15295645","title":"Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro.","date":"2004","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/15295645","citation_count":30,"is_preprint":false},{"pmid":"19893486","id":"PMC_19893486","title":"The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19893486","citation_count":29,"is_preprint":false},{"pmid":"33328293","id":"PMC_33328293","title":"The Rac-GEF Tiam1 Promotes Dendrite and Synapse Stabilization of Dentate Granule Cells and Restricts Hippocampal-Dependent Memory Functions.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33328293","citation_count":29,"is_preprint":false},{"pmid":"35773411","id":"PMC_35773411","title":"YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35773411","citation_count":29,"is_preprint":false},{"pmid":"35240055","id":"PMC_35240055","title":"Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures.","date":"2022","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35240055","citation_count":29,"is_preprint":false},{"pmid":"22302986","id":"PMC_22302986","title":"Tiam1-regulated osteopontin in senescent fibroblasts contributes to the migration and invasion of associated epithelial cells.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22302986","citation_count":28,"is_preprint":false},{"pmid":"29920278","id":"PMC_29920278","title":"Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/29920278","citation_count":27,"is_preprint":false},{"pmid":"33472090","id":"PMC_33472090","title":"Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/33472090","citation_count":27,"is_preprint":false},{"pmid":"18592271","id":"PMC_18592271","title":"Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.","date":"2008","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18592271","citation_count":27,"is_preprint":false},{"pmid":"31597723","id":"PMC_31597723","title":"Tiam1 is Critical for Glutamatergic Synapse Structure and Function in the Hippocampus.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31597723","citation_count":26,"is_preprint":false},{"pmid":"17352239","id":"PMC_17352239","title":"Involvement of Tiam1 in apoptosis induced by bufalin in HeLa cells.","date":"2007","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17352239","citation_count":26,"is_preprint":false},{"pmid":"26386179","id":"PMC_26386179","title":"ApoER2 and Reelin are expressed in regenerating peripheral nerve and regulate Schwann cell migration by activating the Rac1 GEF protein, Tiam1.","date":"2015","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/26386179","citation_count":26,"is_preprint":false},{"pmid":"27539661","id":"PMC_27539661","title":"Involvement of Tiam1, RhoG and ELMO2/ILK in Rac1-mediated phagocytosis in human trabecular meshwork cells.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27539661","citation_count":25,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50058,"output_tokens":12646,"usd":0.169932,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23934,"output_tokens":6098,"usd":0.13606,"stage2_stop_reason":"end_turn"},"total_usd":0.305992,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Tiam1 functions as a GDP-dissociation stimulator (GDS/GEF) for Rho-like GTPases in vitro, with preferential activity toward Rac1. In fibroblasts, Tiam1 induces membrane ruffling identical to constitutively active V12Rac1, and this phenotype is inhibited by dominant-negative N17Rac1, establishing Tiam1 as a Rac-specific GEF that drives actin cytoskeletal remodeling.\",\n      \"method\": \"In vitro GDS assay; dominant-negative Rac1 inhibition; morphological analysis in fibroblasts\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic assay combined with dominant-negative epistasis, replicated across multiple subsequent studies\",\n      \"pmids\": [\"7753201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"N-terminal truncation of Tiam1 activates its oncogenic potential in NIH3T3 cells, establishing Tiam1 as a proto-oncogene whose N-terminal sequences suppress transformation but are required for membrane ruffling. Constitutively active V12Rac1 phenocopies Tiam1-induced oncogenic transformation, placing Rac1 downstream of Tiam1.\",\n      \"method\": \"Overexpression of truncation mutants in NIH3T3 focus formation assay; comparison with V12Rac1\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis with defined phenotypic readouts, consistent with parallel Nature paper\",\n      \"pmids\": [\"8570171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Tiam1 localizes to adherens junctions in epithelial MDCK cells, where it promotes E-cadherin-mediated cell-cell adhesion and suppresses HGF-induced cell scattering and invasion. Expression of Tiam1 or RacV12 in Ras-transformed MDCK cells restores E-cadherin adhesion and causes phenotypic reversion.\",\n      \"method\": \"Ectopic expression, immunolocalization, HGF-induced scattering assay, invasion assay in MDCK cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gain-of-function with defined cellular phenotype, replicated in multiple epithelial contexts\",\n      \"pmids\": [\"9367959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Lysophosphatidic acid (LPA) and other agonists induce threonine phosphorylation of Tiam1 in Swiss 3T3 fibroblasts via protein kinase C. PKC inhibition reduces LPA-stimulated Tiam1 phosphorylation by ~75%, and PKC phosphorylates purified Tiam1 on threonine in vitro.\",\n      \"method\": \"In vivo phosphorylation assay; PKC inhibitor Ro-31-8220; PMA treatment; in vitro kinase assay with purified Tiam1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus in vivo pharmacological validation, single lab\",\n      \"pmids\": [\"9407095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The Tiam1/Rac signaling response in epithelial cells is substrate-dependent: on fibronectin/laminin-1 Tiam1 promotes E-cadherin-mediated adhesion and inhibits migration, while on collagen it promotes migration. PI3-kinase acts upstream of Tiam1 and Rac, as PI3K inhibition blocks Tiam1-induced but not V12Rac-induced effects. Tiam1 localizes to adherens junctions in non-motile cells and to lamellipodia in migrating cells.\",\n      \"method\": \"Substrate-dependent migration/adhesion assays; PI3K inhibition; GST-PAK pulldown for Rac-GTP; immunolocalization\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, PI3K epistasis defined, replicated across substrates\",\n      \"pmids\": [\"9832565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Both protein kinase Cα and Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylate Tiam1 in vivo. CaMKII phosphorylates Tiam1 in vitro and enhances its nucleotide exchange activity toward Rac1 approximately 2-fold. Protein phosphatase 1 dephosphorylates Tiam1 in vitro and abolishes CaMKII-mediated activation.\",\n      \"method\": \"Intracellular Ca2+ manipulation; in vitro kinase assay (CaMKII); in vitro phosphatase assay (PP1); nucleotide exchange activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro kinase/phosphatase assay with functional (GEF activity) readout, single lab\",\n      \"pmids\": [\"10212259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD44v3 isoform physically associates with Tiam1 in breast tumor cells in vivo. The PHn-CC-Ex domain (aa 393–738) of Tiam1 is the primary CD44-binding region (Kd ~0.2 nM by Scatchard analysis). HA binding to CD44v3 stimulates Tiam1-catalyzed Rac1 activation and cell migration; disrupting CD44-Tiam1 interaction with the PHn-CC-Ex fragment blocks both.\",\n      \"method\": \"Co-immunoprecipitation; in vitro binding assay with recombinant fragment; Scatchard plot; Rac1 activation assay; migration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, in vitro binding with Kd determination, functional rescue/block, single lab\",\n      \"pmids\": [\"10636882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Ankyrin binds directly to Tiam1 via the ankyrin repeat domain (ARD), and the 11-aa sequence aa717-727 of Tiam1 is the ankyrin-binding domain. Ankyrin binding to Tiam1 activates GDP/GTP exchange on Rac1. Blocking this interaction with a Tiam1 fragment (aa393-728) inhibits Rac1 activation and breast tumor cell invasion.\",\n      \"method\": \"Co-immunoprecipitation; deletion mutation analysis; in vitro binding assay; GEF activity assay; tumor invasion assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding with defined domain, GEF activity assay, competitive inhibitor used, single lab\",\n      \"pmids\": [\"10893266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The N-terminal pleckstrin homology (N-PH) domain of Tiam1 binds phosphoinositides with rank order PtdIns(3,4,5)P3 > PtdIns(3,4)P2 >> PtdIns(4,5)P2. PtdIns(3,4,5)P3 and PtdIns(3,4)P2 enhance Tiam1 GEF activity in vitro. The N-PH domain is required for PI3K-dependent Rac1 activation and membrane ruffling in cells.\",\n      \"method\": \"Lipid-binding assay; in vitro GEF activity assay; co-expression with constitutively active PI3K; domain deletion mutants\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro lipid-binding and GEF activity assays with domain mutagenesis, single lab\",\n      \"pmids\": [\"10998360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tiam1 localizes to microtubules in the nascent axon growth cone of cultured neurons. Overexpression of Tiam1 induces formation of multiple axon-like neurites, whereas suppression of Tiam1 prevents axon formation and growth cone cytoskeletal reorganization, indicating Tiam1 regulates axon specification through Rac1-dependent actin organization.\",\n      \"method\": \"Tiam1 overexpression and suppression; immunolocalization; cytochalasin D treatment; neuronal morphology analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function with defined morphological readout, single lab\",\n      \"pmids\": [\"11264310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tiam1 preferentially associates with activated GTP-bound Ras through a Ras-binding domain (RBD). Activated Ras and Tiam1 cooperate to produce synergistic Rac-GTP formation in a PI3K-independent manner, establishing Tiam1 as a direct Ras effector that mediates Ras activation of Rac.\",\n      \"method\": \"GST pulldown of GTP-Ras with Tiam1 RBD; Rac-GTP measurement (PAK-PBD pulldown) with PI3K inhibitors; co-expression of activated Ras and Tiam1\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct binding assay plus PI3K-independent epistasis with multiple controls, single lab\",\n      \"pmids\": [\"12134164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tiam1-deficient mice are resistant to Ras-induced skin tumorigenesis. Loss of Tiam1 is associated with increased apoptosis during tumor initiation and impeded proliferation during promotion. Tiam1-deficient primary embryonic fibroblasts resist RasV12-induced focus formation. Tumor number was Tiam1 gene-dose dependent.\",\n      \"method\": \"Tiam1 knockout mice; DMBA/TPA skin tumor model; focus formation assay with primary MEFs\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout model with defined phenotype, gene dosage effect, and in vitro MEF validation\",\n      \"pmids\": [\"12075356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The N-terminal region of Tiam1 (containing PH domain, coiled-coil, and additional sequences) binds the scaffold protein IB2/JIP2. IB2/JIP2 simultaneously binds MLK3, MKK3, and p38 MAPK. Tiam1 binding to IB2/JIP2 potentiates p38 MAP kinase cascade activation but not JNK activation, revealing that scaffold association directs Rac signaling specificity.\",\n      \"method\": \"Yeast two-hybrid; co-immunoprecipitation; p38/JNK kinase assays; domain-deletion mapping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, kinase assays, but single lab\",\n      \"pmids\": [\"12024021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tiam1 interacts with ephrin-B1 and EphA2 and mediates Rac1 activation and neurite outgrowth in response to both ephrin-B1 reverse signaling (via clustered EphB2) and EphA2 forward signaling (via ephrin-A1). Dominant-negative Tiam1 blocks neurite outgrowth induced by these Eph/ephrin signals.\",\n      \"method\": \"Co-immunoprecipitation; Rac1 activation assay; dominant-negative Tiam1 inhibition; neurite outgrowth assay in cortical neurons and neuroblastoma cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus dominant-negative epistasis with functional readout, single lab\",\n      \"pmids\": [\"14988728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tiam1 is required for the formation and maintenance of cadherin-based adherens junctions in MDCK cells. siRNA-mediated knockdown of Tiam1 causes junction disassembly and acquisition of a mesenchymal migratory phenotype. E1A-induced epithelial reversion requires Tiam1 upregulation and Rac activation.\",\n      \"method\": \"siRNA knockdown; E1A expression; Rac activation assay; Tiam1 KO primary MEFs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA loss-of-function with specific adhesion phenotype, confirmed in Tiam1 KO MEFs\",\n      \"pmids\": [\"15138270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Par-3 directly binds the C-terminal region of Tiam1. Knockdown of Par-3 leads to constitutive Rac activation and disrupted tight junction assembly; this is rescued by dominant-negative Rac or by Tiam1 knockdown. Thus Par-3 spatially restrains Tiam1-mediated Rac activity to control tight junction assembly.\",\n      \"method\": \"Co-immunoprecipitation; Par-3 siRNA knockdown; dominant-negative Rac rescue; Tiam1 siRNA; tight junction formation assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding assay, multiple genetic epistasis experiments, replicated independently in parallel study\",\n      \"pmids\": [\"15723052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PAR-3 directly interacts with STEF/Tiam1 and recruits them into the PAR-3-aPKC-PAR-6-Cdc42-GTP complex. This complex mediates Cdc42-induced Rac activation and lamellipodia formation. Disrupting PAR-3-STEF/Tiam1 interaction inhibits Cdc42-induced lamellipodia but not filopodia. STEF/Tiam1 accumulates at the axon tip and is required for neuronal polarity.\",\n      \"method\": \"Co-immunoprecipitation; complex reconstitution; dominant-negative disruption; lamellipodia/filopodia morphology assay; hippocampal neuron imaging\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complex formation, genetic epistasis, independent replication in parallel study\",\n      \"pmids\": [\"15723051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tiam1 is present in dendrites and spines and interacts with the NMDA receptor. NMDA receptor stimulation induces calcium-dependent phosphorylation of Tiam1. RNAi knockdown and dominant-interfering Tiam1 mutants impair dendritic arbor and spine development via Rac1-dependent actin remodeling.\",\n      \"method\": \"Co-immunoprecipitation with NMDAR; in vivo phosphorylation assay; RNAi knockdown; dominant-negative Tiam1; dendritic morphology analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct interaction, phosphorylation, multiple loss-of-function approaches, defined morphological phenotype\",\n      \"pmids\": [\"15721239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tiam1 is required for alpha3beta1 integrin-mediated Rac activation, laminin-5 deposition, cell spreading, and migration in keratinocytes. Tiam1-deficient keratinocytes cannot activate Rac upon alpha3beta1-mediated adhesion and cannot deposit their own LN5 substrate. Tiam1 or V12Rac1 rescues these defects.\",\n      \"method\": \"Tiam1 KO keratinocytes; Rac activation assay (GST-PAK pulldown); V12Rac1 rescue; wound healing/migration assay in vivo\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO cells with defined biochemical and functional phenotypes, V12Rac1 rescue, in vivo validation\",\n      \"pmids\": [\"16330714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tiam1 binds to IRSp53 (an adaptor/effector for Rac and Cdc42). Tiam1 directs IRSp53 preferentially to Rac signaling by enhancing its interaction with active Rac and the WAVE2 scaffold, promoting IRSp53 localization to lamellipodia over filopodia. IRSp53 depletion prevents Tiam1-dependent lamellipodia formation.\",\n      \"method\": \"Co-immunoprecipitation; IRSp53 siRNA depletion; subcellular localization by immunofluorescence; lamellipodia/filopodia morphology assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, siRNA rescue, localization studies, single lab\",\n      \"pmids\": [\"15899863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tiam1 is a Wnt-responsive gene: its expression is up-regulated in intestinal crypts by the canonical Wnt/APC pathway. Tiam1 deficiency in APC-mutant Min mice significantly reduces polyp formation and growth, but enhances malignant invasion, indicating Tiam1 promotes Wnt-driven tumor initiation/growth while restraining malignant conversion.\",\n      \"method\": \"Tiam1 KO × Min mouse cross; polyp counting; Tiam1 siRNA in human CRC cells; Wnt reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic cross with defined tumor phenotype, gene dosage effect, supported by cell-based experiments\",\n      \"pmids\": [\"16249175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAR-3 binds TIAM1 and spatially restricts it to dendritic spines in hippocampal neurons. Depletion of PAR-3 causes formation of multiple filopodia- and lamellipodia-like protrusions resembling activated Rac, indicating that PAR-3 limits TIAM1-mediated Rac-GTP levels to enable proper spine morphogenesis.\",\n      \"method\": \"PAR-3 RNAi; TIAM1 co-immunoprecipitation; spine morphology analysis in hippocampal neurons\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding, loss-of-function, specific morphological phenotype consistent with Rac activation\",\n      \"pmids\": [\"16474385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tiam1 interacts with the p21-Arc subunit of the Arp2/3 complex via its N-terminal PH domain and adjacent coiled-coil region. Tiam1 co-localizes with Arp2/3 at sites of actin polymerization. Deletion of the p21-Arc-binding domain impairs Tiam1 localization and Rac1 activation. Functionally active Tiam1 (but not GEF-deficient mutant) promotes Arp2/3 activation, revealing a self-amplifying Tiam1-Rac-Arp2/3 module.\",\n      \"method\": \"Yeast two-hybrid; co-immunoprecipitation; domain deletion; immunofluorescence co-localization; Rac1 activation assay; WASP inhibitor\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid confirmed by co-IP, domain mutants, GEF-dead mutant control, single lab\",\n      \"pmids\": [\"16599904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TrkB directly binds Tiam1 and phosphorylates Tyr-829 in response to BDNF stimulation, leading to Rac1 activation and lamellipodia formation. A Y829F point mutation in Tiam1 blocks BDNF-induced morphological changes and neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation; site-directed mutagenesis (Y829F); Rac1 activation assay; neurite outgrowth assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis at defined phosphorylation site with functional validation, single lab\",\n      \"pmids\": [\"16801538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The Par-Tiam1 complex (Par3, Par6, PKCzeta, Tiam1) localizes to leading edges of migrating keratinocytes. Tiam1-deficient and Par3-depleted keratinocytes migrate randomly due to failure to maintain front-rear polarity. Par-Tiam1 stabilizes front-rear polarity by stabilizing microtubules; Tiam1 KO cells have unstable microtubules that impair directional but not random migration.\",\n      \"method\": \"Tiam1 KO and Par3 siRNA keratinocytes; chemotaxis assay; live cell imaging; immunoprecipitation; microtubule stability assay\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO and siRNA with defined polarity/migration phenotype, immunoprecipitation complex confirmed, microtubule mechanism defined\",\n      \"pmids\": [\"17825562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"EphB receptor activation by ephrinB1 induces tyrosine phosphorylation and recruitment of Tiam1 to EphB2-NMDAR complexes in a kinase-dependent manner. RNAi knockdown or dominant-negative Tiam1 blocks ephrinB1-induced dendritic spine formation, placing Tiam1 downstream of EphB in Rac1-dependent spine morphogenesis.\",\n      \"method\": \"Co-immunoprecipitation; tyrosine phosphorylation assay; RNAi knockdown; dominant-negative Tiam1; spine density analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct interaction, phosphorylation in complex, two independent loss-of-function approaches with morphological readout\",\n      \"pmids\": [\"17440041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Paracingulin physically interacts with Tiam1 and GEF-H1 in vivo and in vitro, and is required for their efficient recruitment to epithelial junctions. Paracingulin depletion reduces Rac1 activity in a Tiam1-dependent manner during tight junction assembly and delays junction formation.\",\n      \"method\": \"Co-immunoprecipitation; in vitro binding; siRNA knockdown; immunofluorescence; Rac1 activity assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding plus co-IP confirmed, siRNA with functional readout, single lab\",\n      \"pmids\": [\"18653465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Src phosphorylates Tiam1 on Y384, predominantly at adherens junctions. This creates a docking site for Grb2, leading to recruitment of the Grb2-Sos1 complex, ERK activation, and localized calpain-dependent degradation of Tiam1 at AJs, resulting in junction disassembly, cell migration, and EMT.\",\n      \"method\": \"Site-directed mutagenesis (Y384); mass spectrometry; co-immunoprecipitation; ERK activation assay; calpain inhibitor treatment; tumor tissue correlation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphorylation site mutagenesis with mechanistic cascade defined (Src→Y384→Grb2→ERK→calpain→Tiam1 degradation), single lab\",\n      \"pmids\": [\"19285946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The Tiam1 PDZ domain adopts a canonical PDZ fold (crystal structure determined) and binds Syndecan1 C-terminal peptide. Syndecan1 is a physiological Tiam1 binding partner; the PDZ domain mediates cell-matrix adhesion and cell migration.\",\n      \"method\": \"X-ray crystallography; NMR chemical shift perturbation; equilibrium binding; mutagenesis; cell-matrix adhesion assay\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus NMR binding validation plus functional cell assay, single lab\",\n      \"pmids\": [\"20361982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of the Tiam1/2 PHCCEx domain reveals a single globular domain comprising a PH subdomain, antiparallel coiled-coil (CC), and novel three-helical Ex subdomain. Mutational analysis shows CC and Ex subdomains form a positively charged surface for protein binding. Two acidic motifs in binding partners (Motif-I in CD44, ephrinBs, NMDAR; Motif-II in Par3, JIP2) mediate PHCCEx interaction.\",\n      \"method\": \"X-ray crystallography; mutational binding analysis; peptide competition assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with mutational validation and identification of interaction motifs in multiple partners\",\n      \"pmids\": [\"19893486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tiam1 and Rac1 localize to centrosomes during prophase and prometaphase. Tiam1-Rac signaling retards centrosome separation and antagonizes Eg5 (kinesin-5). Tiam1-depleted cells escape monopolar arrest caused by Eg5 inhibition, display slower prometaphase transit, and show increased chromosome congression errors. This identifies Tiam1-Rac as the first antagonist of centrosome separation during prophase.\",\n      \"method\": \"Tiam1 siRNA depletion; centrosome separation quantification; Eg5 inhibitor (monastrol); chromosome congression analysis; immunofluorescence at centrosomes\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown, epistasis with Eg5 inhibitor, in vivo confirmation with Rac1-deficient cells\",\n      \"pmids\": [\"20346677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The Tiam1 and Tiam2 PDZ domains have overlapping but distinct ligand specificities determined by four non-conserved residues in the S0 and S-2 pockets. A Tiam1 PDZ quadruple mutant acquires Tiam2 PDZ specificity, revealing the molecular determinants of ligand selectivity.\",\n      \"method\": \"Combinatorial peptide library screening; equilibrium binding assays; site-directed mutagenesis; double mutant cycle analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — combinatorial library, binding assays, and mutagenesis in single rigorous study\",\n      \"pmids\": [\"21192692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Tiam1 interacts directly with talin, which links integrins to signaling. Tiam1 accumulates at adhesions dependent on talin and the PAR complex. Talin-Tiam1 and PAR complex interactions are required for adhesion-induced Rac1 activation, cell spreading, migration toward integrin substrates, and adhesion turnover.\",\n      \"method\": \"Co-immunoprecipitation; direct binding assay; Rac1 activation assay; cell spreading and migration assays; adhesion turnover measurement\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay, co-IP, functional rescue, single lab\",\n      \"pmids\": [\"23071154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"β2-syntrophin binds Tiam1 and promotes Tiam1-Rac activity at basal cell-cell junctions, generating an apicobasal Rac activity gradient. In contrast, apical Par-3 inhibits Tiam1-Rac activity. This gradient is required for optimal tight junction assembly and apical lumen formation.\",\n      \"method\": \"Co-immunoprecipitation; β2-syntrophin depletion; Rac activity assay; TJ assembly assay; lumen formation assay; constitutively active Rac targeting\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — interaction defined, loss-of-function with Rac activity gradient measured, functional consequence in lumen formation\",\n      \"pmids\": [\"23103911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Tiam1 regulates the Wnt/Dvl/Rac1 pathway in midbrain dopaminergic neurons: Tiam1 interacts with Dvl, facilitates Dvl-Rac1 interaction, and is required for Wnt5a/Dvl-induced Rac1 activation. CK1 negatively regulates Tiam1-Dvl interaction. Tiam1 knockdown impairs DA neuron generation in ventral midbrain neurosphere cultures.\",\n      \"method\": \"Co-immunoprecipitation; Rac1 activation assay; Tiam1 knockdown; neurosphere cultures; DA neuron counting\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, Rac1 activation assay, knockdown with functional phenotype, single lab\",\n      \"pmids\": [\"23109420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CADM1's cytoplasmic domain (type II PDZ-binding motif) directly interacts with the PDZ domain of Tiam1 in ATL cells. This interaction induces lamellipodia formation through Rac activation, promoting leukemic cell invasion.\",\n      \"method\": \"Amino acid alignment; direct binding assay; co-immunoprecipitation; lamellipodia morphology; Rac activation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction demonstrated, Rac activation assay, single lab\",\n      \"pmids\": [\"20215110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NMDA receptor stimulation promotes oligodendrocyte precursor cell (OPC) migration via the Tiam1/Rac1/ERK signaling pathway. Tiam1 co-immunoprecipitates with NMDAR in OPCs. Pharmacological inhibition or shRNA knockdown of Tiam1 abolishes NMDAR-promoted migration.\",\n      \"method\": \"Co-immunoprecipitation; shRNA knockdown; Rac1/ERK activation assays; Boyden transwell and single-cell migration assays; brain slice culture\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, two loss-of-function approaches, defined signaling cascade, single lab\",\n      \"pmids\": [\"24123220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SIRT1 and SIRT2 positively regulate TIAM1 activity and Rac1-GTP levels. SIRT1/2 inhibition leads to increased acetylation of TIAM1. SIRT1 maintains Dishevelled-1 (DVL1) levels to sustain a DVL1-TIAM1 scaffolding complex that promotes Rac activation. Diminished sirtuin activity disrupts DVL1-TIAM1 interaction.\",\n      \"method\": \"Co-immunoprecipitation; TIAM1 acetylation assay; Rac1 activity assay; SIRT1/2 inhibition; siRNA knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, acetylation, Rac activity assay, single lab\",\n      \"pmids\": [\"24362520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HUWE1 E3 ubiquitin ligase ubiquitylates TIAM1 and targets it for proteasomal degradation, predominantly at cell-cell adhesions during HGF-induced scattering. Depletion of HUWE1 or mutation of the TIAM1 ubiquitylation site prevents TIAM1 degradation and antagonizes scattering and invasion. Simultaneous TIAM1 depletion restores migration in HUWE1-depleted cells.\",\n      \"method\": \"Ubiquitylation assay; proteasome inhibitor; HUWE1 knockdown; TIAM1 ubiquitylation site mutagenesis; scattering/invasion assay; lung cancer cell invasion assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ubiquitylation site mutagenesis, epistasis rescue experiment, confirmed in human lung cancer cells\",\n      \"pmids\": [\"25543140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Phosphatidylinositol 5-phosphate (PtdIns5P) binds the DH-PH domains of Tiam1 and activates its GEF activity. In a reconstituted assay with membrane-anchored Rac1-His and PtdIns5P-containing liposomes, intrinsic Tiam1 DH-PH activity is enhanced by the PtdIns5P-enriched environment. This pathway is operative in receptor tyrosine kinase activation, bacterial IpgD expression, and NPM-ALK+ lymphoma invasion.\",\n      \"method\": \"Lipid-binding assay; in vitro GEF activity reconstitution with liposomes; Rac1-His membrane anchoring assay; cell invasion assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro assay with defined lipid-protein interaction and functional GEF activity measurement\",\n      \"pmids\": [\"24905281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"AKT (downstream of EGFR/PI3K) phosphorylates TIAM1 at consensus phosphorylation sites, facilitating interaction with scaffold proteins 14-3-3 and increasing TIAM1 protein stability. TIAM1 is subsequently dephosphorylated and destabilized by PP2A, defining a bidirectional phosphorylation/dephosphorylation mechanism controlling TIAM1 stability and EGFR-driven Rac1 activation.\",\n      \"method\": \"AKT in vitro kinase assay; 14-3-3 co-immunoprecipitation; PP2A inhibitor/overexpression; protein stability assay; TIAM1 knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay, co-IP with 14-3-3, PP2A dephosphorylation validated, single lab\",\n      \"pmids\": [\"25746002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The CUL3-KBTBD6/KBTBD7 ubiquitin ligase complex mediates ubiquitylation and proteasomal degradation of TIAM1. KBTBD6/7 employ ATG8-family-interacting motifs to bind GABARAP proteins. TIAM1 ubiquitylation depends on its binding to GABARAP proteins on vesicles, thereby spatially restricting membrane-associated TIAM1 and RAC1 signaling.\",\n      \"method\": \"Ubiquitylation assay; KBTBD6/7 knockdown; GABARAP co-immunoprecipitation; proteasome inhibitor; Rac1 activity assay; actin morphology analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ubiquitylation assay, defined E3 complex, GABARAP-dependent mechanism, multiple functional readouts\",\n      \"pmids\": [\"25684205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cdk1 phosphorylates Tiam1 on S1466 during mitosis. This phosphorylation is required for activation of group I p21-activated kinases (Pak1 and Pak2) on centrosomes in prophase. Pak1 and Pak2 counteract centrosome separation downstream of Tiam1, and Pak1/2 depletion allows cells to escape monopolar arrest by Eg5 inhibition.\",\n      \"method\": \"Site-directed mutagenesis (S1466); in vitro Cdk1 kinase assay; centrosome Pak activation assay; siRNA knockdown of Pak1/2; monopolar arrest assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay, site-directed mutagenesis at defined Cdk1 site, downstream kinase epistasis, single lab\",\n      \"pmids\": [\"26078008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tiam1 and Rac1 form a complex with the transcription factor RORγt in the nucleus of Th17 cells and together bind and activate the Il17a promoter. Tiam1 genetic deficiency weakens IL-17A expression and attenuates experimental autoimmune encephalomyelitis (EAE).\",\n      \"method\": \"Co-immunoprecipitation of nuclear Tiam1-Rac1-RORγt complex; ChIP assay at Il17 promoter; Tiam1 KO mice; EAE model; pharmacological Rac1 inhibition\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of nuclear complex, ChIP, in vivo KO phenotype, single lab\",\n      \"pmids\": [\"27725632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TIAM1 antagonizes TAZ/YAP by two spatially distinct mechanisms: (1) in the cytoplasm, TIAM1 localizes to the destruction complex and promotes TAZ degradation by enhancing its interaction with βTrCP; (2) in the nucleus, TIAM1 suppresses TAZ/YAP interaction with TEAD transcription factors, inhibiting EMT-related gene expression and CRC cell invasion.\",\n      \"method\": \"Nuclear/cytoplasmic fractionation; co-immunoprecipitation of TIAM1 with destruction complex and βTrCP; TEAD interaction assay; TAZ degradation assay; CRC cell invasion assay\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two mechanistically distinct compartment-specific interactions defined, multiple biochemical assays, functional invasion readout\",\n      \"pmids\": [\"28416184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"EndoA3 (endophilin A3) binds TIAM1 directly, and this interaction competes with EndoA3 membrane binding. When EndoA3-membrane interaction is disrupted, TIAM1 binding is favored, leading to TIAM1 and small GTPase activation and increased cell motility/metastasis in vivo.\",\n      \"method\": \"Direct binding assay (EndoA3-TIAM1); competition with membrane liposomes; GTPase activation assay; in vivo metastasis model in zebrafish\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding, competition assay, in vivo validation, single lab\",\n      \"pmids\": [\"29920278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tiam1 orchestrates synaptic structural and functional plasticity in anterior cingulate cortex (ACC) neurons via actin cytoskeleton reorganization and synaptic NMDAR stabilization. Tiam1-mediated synaptic plasticity drives ACC hyperactivity underlying chronic pain-induced depressive-like behaviors. Ketamine blocks Tiam1-mediated maladaptive synaptic plasticity to produce antidepressant-like effects.\",\n      \"method\": \"Tiam1 conditional KO; electrophysiology; spine morphology imaging; actin dynamics assay; NMDAR surface expression; chronic pain mouse models; behavioral assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with electrophysiological and morphological phenotypes, pharmacological intervention, single lab\",\n      \"pmids\": [\"36519542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss-of-function variants in TIAM1 (bi-allelic missense) cause developmental delay, intellectual disability, and seizures. In Drosophila, loss of the ortholog still life (sif) reduces survival, causes climbing defects and seizures. Human TIAM1 reference cDNA partially rescues sif loss-of-function phenotypes; patient variants show reduced rescue ability confirming partial loss of function.\",\n      \"method\": \"Human genetics (bi-allelic variants in patients); Drosophila sif KO; in vivo rescue with TIAM1 reference vs. patient variant cDNAs; ectopic expression toxicity assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human genetics validated by Drosophila ortholog rescue experiments with allele-level functional analysis\",\n      \"pmids\": [\"35240055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"YAP1-TEAD4 transcriptionally activates TIAM1 expression by binding to an enhancer region of the TIAM1 gene. TIAM1 upregulation increases RAC1 activity and induces invadopodia formation in breast cancer cells.\",\n      \"method\": \"ChIP assay for TEAD4 at TIAM1 enhancer; YAP1 knockdown/overexpression; TIAM1 expression measurement; RAC1 activity assay; invadopodia assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP defining transcriptional activation, functional readout (RAC1 activity, invadopodia), single lab\",\n      \"pmids\": [\"35773411\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TIAM1 is a multi-domain Rac1-specific guanine nucleotide exchange factor (GEF) whose DH-PH catalytic module is activated downstream of diverse receptors (NMDAR, EphB/EphA, TrkB, EGFR, integrins, S1P1) and signaling lipids (PtdIns(3,4,5)P3, PtdIns5P); its activity is positively regulated by CaMKII-mediated phosphorylation of defined sites (enhanced GEF activity), Cdk1-mediated phosphorylation at S1466 (centrosomal Pak activation during mitosis), and TrkB-mediated phosphorylation at Y829, and negatively regulated by Src-mediated Y384 phosphorylation that creates a Grb2 docking site leading to ERK-calpain-dependent localized degradation, as well as by ubiquitin-mediated proteasomal degradation via HUWE1 and CUL3-KBTBD6/7 E3 ligases (the latter requiring GABARAP-mediated membrane recruitment); TIAM1 is anchored to functionally distinct subcellular compartments through its PDZ domain (Syndecan1), PHn-CC-Ex domain (Par3, CD44, NMDAR, ephrinBs), and N-terminal PH domain (phosphoinositides and Arp2/3 complex p21-Arc subunit), and in the Par3-Par6-aPKC polarity complex it spatially restricts Rac1 activation to control epithelial tight junction assembly, apical-basal polarity, axon specification, dendritic spine morphogenesis, and front-rear polarity in migrating cells; TIAM1 also functions non-canonically in the nucleus where it forms a complex with Rac1 and RORγt to drive Il17a transcription in Th17 cells, and antagonizes TAZ/YAP by promoting TAZ degradation at the cytoplasmic destruction complex and blocking TAZ/YAP-TEAD interaction in the nucleus.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TIAM1 is a Rac1-specific guanine nucleotide exchange factor (GEF) that couples diverse upstream receptors and lipid signals to localized Rac1-driven actin remodeling, governing cell adhesion, polarity, migration, and neuronal morphogenesis [#0, #4]. Its catalytic output toward Rac1 was first defined biochemically in vitro and confirmed by Rac1-dependent membrane ruffling in fibroblasts, where N-terminal truncation unmasks oncogenic transforming activity that is phenocopied by activated Rac1 [#0, #1]. TIAM1 acts as a direct Ras effector through a Ras-binding domain, synergizing with activated Ras to generate Rac-GTP independently of PI3K, and Tiam1-deficient mice are resistant to Ras-induced skin tumorigenesis, establishing it as a physiological proto-oncogene [#10, #11]. GEF activity is gated by phosphoinositides binding the N-terminal PH domain — PtdIns(3,4,5)P3 and PtdIns5P stimulate exchange activity — and by phosphorylation: CaMKII and TrkB-mediated Y829 phosphorylation enhance activity, Cdk1 phosphorylation of S1466 drives centrosomal Pak activation in mitosis, while Src phosphorylation of Y384 creates a Grb2 docking site triggering ERK/calpain-dependent local degradation [#8, #39, #5, #23, #42, #27]. TIAM1 levels are further controlled by HUWE1 and CUL3-KBTBD6/7 (the latter requiring GABARAP-mediated membrane recruitment) ubiquitin-dependent degradation [#38, #41]. Spatial control of Rac1 activation is achieved through compartment-specific anchoring: the PHn-CC-Ex domain binds CD44, NMDAR, ephrinBs, and Par3, the PDZ domain binds Syndecan1 and CADM1, and the N-PH domain binds the Arp2/3 p21-Arc subunit, forming a self-amplifying Tiam1-Rac-Arp2/3 module [#29, #28, #22]. Within the Par3-Par6-aPKC polarity complex TIAM1 restricts Rac1 activation to control tight junction assembly, apical-basal and front-rear polarity, axon specification, and dendritic spine morphogenesis [#15, #16, #17, #24]. Non-canonically, TIAM1 forms a nuclear complex with Rac1 and RORγt to drive Il17a transcription in Th17 cells and antagonizes TAZ/YAP by promoting TAZ degradation and blocking TAZ/YAP-TEAD interaction [#43, #44]. Bi-allelic loss-of-function TIAM1 variants cause developmental delay, intellectual disability, and seizures, validated by rescue of the Drosophila sif ortholog [#47].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established TIAM1's core biochemical identity — whether it was an enzyme acting on Rho GTPases — by showing it is a Rac-preferential GEF whose activity drives actin remodeling and oncogenic transformation.\",\n      \"evidence\": \"In vitro GDS assay and dominant-negative Rac1 epistasis in fibroblasts; N-terminal truncation focus formation assay in NIH3T3\",\n      \"pmids\": [\"7753201\", \"8570171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the upstream receptors activating Tiam1\", \"Did not resolve how the N-terminus autoinhibits the catalytic module\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Connected TIAM1's GEF activity to epithelial biology by showing it localizes to adherens junctions and promotes E-cadherin adhesion while suppressing invasion, framing context-dependent control of motility versus adhesion.\",\n      \"evidence\": \"Ectopic expression, immunolocalization, and HGF scattering/invasion assays in MDCK cells; PKC-dependent threonine phosphorylation assays\",\n      \"pmids\": [\"9367959\", \"9407095\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism switching Tiam1 between junction stabilization and migration not yet defined\", \"Functional consequence of PKC phosphorylation on GEF activity unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Resolved how upstream signals reach TIAM1 by placing PI3-kinase upstream and showing the Tiam1/Rac response is substrate (ECM)-dependent, with distinct localization in motile versus non-motile cells.\",\n      \"evidence\": \"Substrate-dependent migration/adhesion assays, PI3K inhibition epistasis, GST-PAK pulldowns, and immunolocalization in epithelial cells\",\n      \"pmids\": [\"9832565\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PI3K-product engagement by Tiam1 not yet shown biochemically\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined post-translational positive regulation by showing CaMKII phosphorylation enhances Tiam1 exchange activity and PP1 reverses it, linking calcium signaling to Rac activation.\",\n      \"evidence\": \"In vitro CaMKII and PP1 assays with nucleotide exchange readout; intracellular calcium manipulation\",\n      \"pmids\": [\"10212259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphosites not mapped in this study\", \"Magnitude of activation modest (~2-fold)\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified the membrane and lipid inputs that activate TIAM1 — direct phosphoinositide binding by the N-PH domain (PtdIns(3,4,5)P3 preferred) and physical scaffolding by CD44v3 and ankyrin — explaining how PI3K and adhesion receptors engage the GEF.\",\n      \"evidence\": \"Lipid-binding and in vitro GEF assays with domain mutants; co-IP, Scatchard binding, and invasion assays for CD44 and ankyrin\",\n      \"pmids\": [\"10998360\", \"10636882\", \"10893266\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How lipid binding mechanistically relieves autoinhibition not structurally defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed TIAM1 as a direct Ras effector and demonstrated its in vivo requirement for Ras-driven tumorigenesis, connecting its GEF biochemistry to oncogenic signaling, while also showing scaffold (JIP2/IB2) association directs MAPK pathway specificity.\",\n      \"evidence\": \"RBD pulldown of GTP-Ras with PI3K-independent Rac-GTP epistasis; Tiam1 KO mice in DMBA/TPA skin model; yeast two-hybrid and kinase assays for JIP2\",\n      \"pmids\": [\"12134164\", \"12075356\", \"12024021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ras-binding integrates with lipid/scaffold inputs unresolved\", \"Tissue-specificity of Tiam1 oncogenic requirement not generalized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established TIAM1 as the spatially restricted Rac activator within the Par3-Par6-aPKC polarity complex and as the receptor-coupled GEF in neurons, controlling tight junctions, lamellipodia, axon specification, and dendritic/spine morphogenesis.\",\n      \"evidence\": \"Co-IP, complex reconstitution, genetic epistasis (Par3/Tiam1/Rac), and morphological assays in MDCK cells, hippocampal neurons, and dendrites; NMDAR co-IP and phosphorylation\",\n      \"pmids\": [\"15723052\", \"15723051\", \"15721239\", \"16330714\", \"15899863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Par3 binding biochemically restrains GEF activity not fully defined\", \"Cross-talk between integrin and polarity-complex anchoring unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined receptor-specific activation modes — TrkB-mediated Y829 phosphorylation and EphB-NMDAR recruitment — and a self-amplifying Tiam1-Rac-Arp2/3 module via N-PH/p21-Arc binding, linking TIAM1 to growth-factor and Eph signaling in neurons.\",\n      \"evidence\": \"Y829F mutagenesis with neurite outgrowth; EphB2-NMDAR co-IP and spine assays; yeast two-hybrid and co-IP for p21-Arc with GEF-dead controls\",\n      \"pmids\": [\"16801538\", \"17440041\", \"16599904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of each receptor input in vivo not partitioned\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided structural and degradative regulatory detail — PDZ and PHCCEx domain crystal structures defining partner-binding surfaces and motifs, and the Src→Y384→Grb2→ERK→calpain cascade driving localized Tiam1 degradation at junctions.\",\n      \"evidence\": \"X-ray crystallography of PDZ and PHCCEx domains with mutational/peptide validation; Y384 mutagenesis, mass spectrometry, and calpain-inhibitor assays\",\n      \"pmids\": [\"20361982\", \"19893486\", \"19285946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full-length autoinhibited GEF not determined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Uncovered a mitotic role by showing Tiam1-Rac localizes to centrosomes and antagonizes centrosome separation and Eg5, expanding TIAM1 function beyond interphase actin control.\",\n      \"evidence\": \"Tiam1 siRNA with centrosome separation quantification, monastrol/Eg5 epistasis, and chromosome congression analysis\",\n      \"pmids\": [\"20346677\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mitotic activator of centrosomal Tiam1 not identified in this study (resolved 2015)\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Refined spatial Rac control by defining talin, β2-syntrophin, and Dvl interactions that establish adhesion-site recruitment and an apicobasal Rac activity gradient opposing apical Par3.\",\n      \"evidence\": \"Co-IP and direct binding, depletion with Rac activity gradient measurement, and lumen/junction/migration assays in epithelial and neuronal systems\",\n      \"pmids\": [\"23071154\", \"23103911\", \"23109420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab interaction data for several partners without reciprocal structural mapping\", \"How opposing apical/basal inputs are integrated dynamically unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established ubiquitin- and lipid-dependent control of TIAM1 abundance and localization via HUWE1 and CUL3-KBTBD6/7, the latter requiring GABARAP-mediated vesicle recruitment, plus acetylation control by SIRT1/2.\",\n      \"evidence\": \"Ubiquitylation site mutagenesis and epistasis rescue (HUWE1); KBTBD6/7 knockdown with GABARAP co-IP; acetylation and Rac activity assays (SIRT1/2)\",\n      \"pmids\": [\"25543140\", \"25684205\", \"24362520\", \"24905281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between competing E3 ligases in different compartments not resolved\", \"Whether PtdIns5P activation and degradation occur on the same vesicle pools unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the mitotic activator and additional stability control — Cdk1 phosphorylation of S1466 driving centrosomal Pak1/2 activation, and AKT/14-3-3/PP2A bidirectional control of TIAM1 stability downstream of EGFR.\",\n      \"evidence\": \"S1466 mutagenesis with in vitro Cdk1 assay and Pak epistasis; AKT kinase assay, 14-3-3 co-IP, and PP2A stability assays\",\n      \"pmids\": [\"26078008\", \"25746002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Cdk1 site phosphorylation couples to Pak activation biochemically not detailed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed non-canonical, compartment-segregated functions — nuclear Tiam1-Rac1-RORγt driving Il17a transcription, and dual cytoplasmic/nuclear antagonism of TAZ/YAP — establishing transcriptional and Hippo-pathway roles distinct from cytoskeletal GEF activity.\",\n      \"evidence\": \"Nuclear complex co-IP and ChIP with Tiam1 KO EAE model; fractionation, βTrCP/destruction-complex and TEAD interaction assays with CRC invasion readouts\",\n      \"pmids\": [\"27725632\", \"28416184\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether nuclear functions require GEF catalytic activity not fully dissected\", \"Single-lab evidence for each non-canonical mechanism\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked TIAM1 to human disease and complex physiology — bi-allelic loss-of-function variants causing developmental delay/intellectual disability/seizures, synaptic plasticity in chronic pain-induced depression, and YAP1-TEAD4 transcriptional activation of TIAM1 in cancer invasion.\",\n      \"evidence\": \"Human genetics with Drosophila sif rescue; conditional KO with electrophysiology/behavior; ChIP and invadopodia assays\",\n      \"pmids\": [\"35240055\", \"36519542\", \"35773411\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic basis of seizure/ID phenotype at the neuronal circuit level incomplete\", \"Reciprocal YAP-TIAM1 regulation (TIAM1 inhibits TAZ/YAP yet YAP1 activates TIAM1) not reconciled\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many competing inputs (lipids, receptor phosphorylation, scaffolds, E3 ligases, acetylation) are integrated on a single autoinhibited full-length TIAM1 molecule to produce spatially and temporally precise Rac1 activation remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length structure showing the autoinhibited-to-active transition\", \"Quantitative hierarchy among activating versus degradative inputs unknown\", \"Mechanistic relationship between cytoskeletal GEF and nuclear transcriptional roles undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5, 7, 8, 39]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [8, 39]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [15, 16, 24, 26]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [43, 44]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4, 8, 18]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [9, 22, 24]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [30, 42]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [43, 44]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [44]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 10, 23, 25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 20, 38, 44, 48]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [30, 42]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [38, 41]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 17, 25, 46]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [43]}\n    ],\n    \"complexes\": [\n      \"Par3-Par6-aPKC polarity complex\",\n      \"Tiam1-Rac1-RORγt nuclear complex\",\n      \"EphB2-NMDAR complex\",\n      \"Wnt destruction complex\"\n    ],\n    \"partners\": [\n      \"RAC1\",\n      \"PARD3\",\n      \"CD44\",\n      \"HRAS\",\n      \"TRKB\",\n      \"SDC1\",\n      \"GABARAP\",\n      \"DVL1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":9,"faith_pct":88.88888888888889}}